Auditory brainstem response findings in a group of neurologically compromised children: a retrospective study by Baillieu, Karen Mary
1 | P a g e  
 
 
 
 
AUDITORY BRAINSTEM RESPONSE FINDINGS IN A GROUP OF 
NEUROLOGICALLY COMPROMISED CHILDREN: A RETROSPECTIVE 
STUDY. 
 
Karen Mary Baillieu 
516 855 
 
 
 
A Research Report submitted to the Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, in partial fulfilment of the requirements for the degree of Master of Science in 
Medicine in Child Health and Neurodevelopment. 
 
 
Johannesburg, 2013 
2 | P a g e  
 
Table of Contents 
 
DECLARATION ......................................................................................................................................... 4 
Acknowledgements ................................................................................................................................. 5 
List of Abbreviations ............................................................................................................................... 6 
List of Figures .......................................................................................................................................... 7 
List of Tables ........................................................................................................................................... 8 
List of Appendices ................................................................................................................................... 9 
Abstract ................................................................................................................................................. 10 
1. Introduction ...................................................................................................................................... 12 
Literature Review .............................................................................................................................. 12 
Early Detection of Hearing Loss .................................................................................................... 12 
Early Intervention for Neurologically Disordered Populations ..................................................... 14 
The Burden of Disease .................................................................................................................. 15 
Hearing Function and Neurological Disorders .............................................................................. 21 
Assessing Hearing Function in Children ........................................................................................ 24 
Assessing Hearing in Special Needs Populations .......................................................................... 25 
The ABR Test ................................................................................................................................. 26 
ABR in Neurologically Compromised Children .............................................................................. 29 
2. Methodology ..................................................................................................................................... 33 
2.1. Aims and Objectives ................................................................................................................... 33 
2.2. Research Design ......................................................................................................................... 33 
2.3. Participants ................................................................................................................................ 35 
2.4. Test Protocol .............................................................................................................................. 36 
2.5. Data Analysis .............................................................................................................................. 37 
2.6. Reliability and Validity ................................................................................................................ 38 
2.6.1. Reliability ............................................................................................................................. 38 
2.6.2. Validity ................................................................................................................................ 39 
2.6.3. Bias ...................................................................................................................................... 40 
2.7. Ethical Considerations ................................................................................................................ 40 
3. Results ............................................................................................................................................... 42 
3.1. Demographic Profile .................................................................................................................. 42 
3.2. Results of the ABR Test .............................................................................................................. 42 
3.3. Results of Behavioural Testing ................................................................................................... 43 
3 | P a g e  
 
3.4. ABR Compared to Behavioural Testing Results ......................................................................... 45 
3.5. Results per Pathology ................................................................................................................ 47 
4. Discussion .......................................................................................................................................... 51 
Diagnosis of Hearing Status .............................................................................................................. 51 
Behavioural Testing in Neurologically Compromised Populations ................................................... 53 
Difficulty Obtaining Behavioural Responses in Neurocompromised Populations ............................ 55 
Hearing Loss with Regard to Diagnosis ............................................................................................. 57 
HPCSA Risk Factors of Hearing Loss .................................................................................................. 61 
Early Intervention and Neurological Disorder .................................................................................. 62 
5. Conclusion ......................................................................................................................................... 64 
6. Recommendations and Implications for the Study........................................................................... 65 
7. Limitations of the Study .................................................................................................................... 67 
8. References ........................................................................................................................................ 68 
9. Appendices ........................................................................................................................................ 80 
Appendix 1: Severity of Hearing Loss ................................................................................................ 80 
Appendix 2: Correction Factors for ABR Testing ............................................................................... 81 
Appendix 3: Letter to the Ethics Committee at Chris Hani Baragwanath Academic Hospital 
Requesting Permission to Use Patient Data ..................................................................................... 82 
Appendix 4: Letter of Permission from the Head of Department of Audiology at Chris Hani 
Baragwanath Academic Hospital ...................................................................................................... 84 
Appendix 5: Medical Ethics Committee Clearance Certificate ......................................................... 85 
Appendix 6: Spreadsheet Containing a Summary of All Data, Per Participant ................................. 87 
 
 
 
 
 
 
4 | P a g e  
 
DECLARATION 
 
I, Karen Mary Baillieu, declare that this Research Report is my own, unaided work.  It is being 
submitted for the Degree of Master of Science in Medicine at the University of the Witwatersrand, 
Johannesburg.  It has not been submitted before for any degree or examination at any other 
University. 
 
 
_______________________________________ 
Karen Baillieu 
 
 
____________________day of _______________________20____________in________________ 
 
 
 
 
 
 
 
5 | P a g e  
 
Acknowledgements 
 
The researcher would like to thank the following people who contributed this study: 
 Professor Katijah Khoza-Shangase for her constant advice, guidance, suggestions and 
supervision. Her availability and enthusiasm, calm demeanor and knowledge were 
invaluable in the completion of this study. 
 Professor Lorna Jacklin for her knowledge, supervision, counsel and direction. Her ideas and 
suggestions were extremely helpful, without which this study could not have come to 
fruition. 
 The Audiology Department at Chris Hani Baragwanath Academic Hospital for opening their 
archive so readily and allowing the results to be utilized for this study. 
 My friends for their advice, support, optimism, and for generally being there for me through 
the entire process. 
 My family, without whom I could not have done this Masters Degree. They never doubted 
me, always offered encouragement and advice, and never once complained when I was 
unavailable or “rather difficult”. 
 
 
 
 
 
 
 
 
 
 
6 | P a g e  
 
List of Abbreviations 
 
AABR Automated Auditory Brainstem Response 
ABR Auditory Brainstem Response 
AIDS Acquired Immunodeficiency Syndrome 
ASD Autism Spectrum Disorder 
ASHA American Speech and Hearing Association 
CHBAH Chris Hani Baragwanath Academic Hospital 
CP Cerebral Palsy 
CPA Conditioned Play Audiometry 
CSOM Chronic Suppurative Otitis Media 
dB Decibel 
dBeHL Decibel Estimated Hearing Level 
dBHL Decibel Hearing Level 
dBnHL Decibel Normal Hearing Level 
HIE Hypoxic Ischemic Encephalopathy 
HIV Human Immunodeficiency Virus 
HIV/AIDS Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome 
HPCSA Health Professions Council of South Africa 
Hz Hertz 
kHz Kilohertz 
ms Milliseconds 
NICU Neonatal Intensive Care Unit 
OAE Otoacoustic Emmission 
Ω Ohm 
RVD Retroviral Disease 
SNHL Sensorineural Hearing Loss 
TBM Tuberculosis Meningitis 
UNAIDS Joint United Nations Programme on HIV/AIDS 
VRA Visual Reinforcement Audiometry 
WHO World Health Organization 
WMA World Medical Association 
 
7 | P a g e  
 
List of Figures 
 
Figure 1: Bar Graph to Show the Audiological Results of Behavioural Testing   
                  …………..………………………………………………………………………………………………………….……… Page 44    
Figure 2: Pie Chart to Show to Compare ABR Audiological Results with those obtained Behaviourally   
                 ………………………………………………………………………………………………………………………………. Page 46 
Figure 3: Pie Chart to Show the Pathologies Presented in the Sample  
                 ……………………………..………..……………………………………………………………………………...……… Page 47 
Figure 4: Bar Chart to Show the Number of Hearing Losses Diagnosed on ABR and Behavioural  
                 Testing for the 6 Main Pathologies ……..…………………..……………………………………….……. Page 48 
 
 
 
 
 
 
 
 
8 | P a g e  
 
List of Tables 
 
Table 1: Table to Show the Description of Hearing Status and the Number of Ears Presenting with  
                Each …………………………………………………………………………………………………………………….…. Page 43 
Table 2: Table to Show the Results of Behavioural Compared to ABR Testing in the Same Ear  
                ……………………………………………………………………….……………………………………………….……… Page 45 
Table 3: Table to Show the Number of Children Presenting with Normal Hearing in Behavioural and  
                ABR Testing per Pathology  …………………………………………………………………………….………. Page 49 
Table 4: Table to Show the Number and Percentage of Patients for Whom No Results were Obtained  
                Behaviourally …………………………………………….…………………………………………………….…….. Page 49 
 
 
 
 
 
 
 
9 | P a g e  
 
List of Appendices 
 
Appendix 1:  Severity of Hearing Loss 
Appendix 2:  Correction Factors for ABR Testing 
Appendix 3:  Letter to the Ethics Committee at Chris Hani Baragwanath Academic Hospital  
                        Requesting Permission to Use Patient Data 
Appendix 4:  Letter of Permission from the Head of Department of Audiology at Chris Hani  
                        Baragwanath Academic Hospital 
Appendix 5:  Medical Ethics Committee Clearance Certificate 
Appendix 6:   Spreadsheet Containing a Summary of All Data, Per Participant 
 
 
 
 
 
 
 
 
 
 
10 | P a g e  
 
Abstract 
 
Objective:  There is a higher prevalence of hearing loss in children with diagnosed neurological 
disorders than the general paediatric population. It is therefore essential that these children have 
their hearing assessed. Conventional behavioural audiometry requires participation from the child, 
and in a majority of this population with neurological pathology this is not always possible owing to 
their neurocompromised state. These children will have to undergo objective testing, such as the 
Auditory Brainstem Response (ABR) in order to obtain estimated hearing thresholds, as this requires 
no active involvement from the patient. This study therefore aims to describe the audiological ABR 
findings in order to determine hearing function in this group and to establish a relationship between 
audiological ABR findings to behavioural audiometry findings where these exist in a group of 
neurologically disordered children in a tertiary hospital in South Africa. 
Methods: A retrospective review was conducted on 40 ABR patient records of children between the 
ages of 5 months and 10 years diagnosed with a neurological disorder. Behavioural audiometry 
results were then sought for these children, where these existed. Hearing status was described for 
each child per ear for both objective and behavioural results, and descriptive statistics were 
conducted. 
Results: 56.25 % (n=45) of ears in this study presented with normal hearing on ABR testing. No 
behavioural audiometry results were obtained in 72.5 % (n=58) of ears in this study. Results 
correlated between ABR and behavioural testing for only 7.5% (n=8) of ears tested and in all eight of 
these ears the hearing result was within normal hearing limits. Twelve and a half percent (n=10) of 
ears were misdiagnosed on behavioural testing. More premature infants were able to be tested 
behaviourally when compared to other pathologies. Cerebral palsy, Down’s Syndrome, prematurity 
and RVD were the pathologies in which the most hearing losses were diagnosed. 
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Conclusions: Behavioural audiometry appears a largely unreliable method of hearing testing in 
children diagnosed with neurological disorders as results were obtained in only 27.5 % of the study 
sample; however it remains the gold standard in paediatric hearing testing in order to evaluate the 
entire auditory system and provides information on how a child processes sound, unlike ABR testing 
which only provides hearing information up to the auditory brainstem. This study highlights the high 
prevalence of hearing problems in children with neurological disorders and therefore the 
importance of hearing testing in this population. Hearing thresholds should be established for 
subsequent remediation via objective testing. Conditioning should continue simultaneously for a 
behavioural audiological test battery with adaptations for the child’s developmental ability. 
 
Key Words: Neurological disorder; paediatric; hearing loss; ABR; behavioural audiometry;          
                      South Africa 
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1. Introduction 
 
Literature Review 
 
Early Detection of Hearing Loss 
 
Hearing loss is a common sensory disability in children, with reports indicating this to be the most 
common sensory disability in the United States of America (Topol, Girard, St. Pierre, Tucker & Vohr, 
2011). One to three per 1000 newborns are diagnosed with a congenital hearing loss in the United 
States (Topol et al., 2011), and one per 840 live births in the United Kingdom (Proops & Acharya, 
2009). A reported 0.76 per 1000 children are diagnosed with a delayed-onset hearing loss between 
the age of 3 and 6 years in China (Lu et al., 2011). In a study conducted in the United Kingdom, 
congenital hearing loss was diagnosed in 1.06 per 1000 births, and this increased to 1.65 per 1000 
children by the age of 9 years (Fortnum, Summerfield, Marshall, Davis & Bamford, 2001). 
Hearing loss has been reported to be more common in developing countries. Of the 800 000 children 
born with or acquiring a bilateral permanent hearing loss of 40 dB or worse each year, 90 % reside in 
developing countries such as South Africa (Friderichs, Swanepoel & Hall, 2012). A previous study 
found a prevalence rate of three per 1000 for the private healthcare setting and six per 1000 in the 
public health setting in South Africa (Swanepoel, Storbeck & Friedland, 2009). 
Many studies have shown the benefits of identifying a hearing loss as early as possible (Topol et al., 
2011; Swanepoel et al., 2012; Swanepoel et al., 2009; Meyer, Swanepoel, le Roux & van der Linde, 
2012; Fortnum et al., 2001). Late detection of hearing loss has adverse effects on the child’s 
linguistic, “psychosocial, emotional and cognitive development” (Meyer et al., 2012, p. 699). Late 
detection of hearing loss also decreases the child’s quality of life (Fortnum et al., 2001). 
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Conversely, the earlier the detection of the hearing loss and the intervention is provided, the better 
the child’s expressive speech and language will be (Friedrich et al., 2012). Early detection and 
intervention will decrease the burden of permanent hearing loss, and result in better educational 
opportunities (Meyer et al., 2012). 
The aim of screening programmes is the early identification of hearing loss in order to improve long-
term outcomes (Rai & Thakur, 2013). Cost-effectiveness studies of screening programmes identifying 
congenital hearing loss are in their infancy (Kemper & Downs, 2012). Preliminary data in the United 
States of America have shown that hearing screening programmes have proven cost-effective and 
that these programmes are beneficial (Kemper & Downs, 2012). 
In South Africa, The Health Professions Council of South Africa (HPCSA) identified populations at risk 
of developing a hearing loss (Swanepoel, 2007). These children should, according to the HPCSA 
(Swanepoel, 2007, p. 28), have their hearing screened at birth if they present with any of these 
identifying factors: 
 An illness or condition requiring admission of 48 hours or greater to a Neonatal Intensive 
Care Unit (NICU) 
 Stigmata or other findings associated with a syndrome known to include a sensorineural 
and/or conductive hearing loss 
 Family history of permanent childhood sensorineural hearing loss 
 Craniofacial abnormalities, including those with morphological abnormalities of the pinna 
and ear canal 
 In-utero infection such as cytomegalovirus, herpes, toxoplasmosis, rubella, HIV, or malaria 
In addition, children with postnatal infections associated with sensorineural hearing loss including 
bacterial meningitis should be screened after a diagnosis of the infection (Swanepoel, 2007). 
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In South Africa, 85% of the population access public health care, which offers medical care either 
free of charge or at a reduced rate (Swanepoel et al., 2009). According to a recent survey-based 
study, only 7.5% of public hospitals in South Africa offer infant hearing screening, and only one 
hospital offered universal screening (Swanepoel et al., 2009). It can therefore be said that 90% of 
babies born in the public health setting in South Africa are not afforded the opportunity of newborn 
hearing screening (Swanepoel et al., 2009). 
 
Early Intervention for Neurologically Disordered Populations 
 
A large number of children in developing countries present with neurological disorders, which cause 
high rates of mortality and long-term morbidity (Newton & Neville, 2009). The World Health 
Organization (WHO) Guidelines, as cited in the Paediatric Neurology and Child Development Services 
in South Africa Report (Department of Health, 2003), states that of the estimated 18 million children 
in South Africa, 10 % (or 1.8 million) will have a significant neurological disorder. This is in keeping 
with the global Burden of Disease, which has found that “mental and neurological disorders account 
for 9.8 % of the total burden of disease in low- and middle-income countries” (Patel, Goel & Desai, 
2009, p. 37). 
Neurological disorders in developing countries face twin difficulties. These pathologies are not only 
diagnosed less in these countries, a study in Zambia found that patients with these diseases receive 
less treatment for their condition, largely as a result of the lack of neurological expertise in these 
countries (Siddiqi, Atadzhanov, Birbeck & Koralnik, 2010). According to Siddiqi et al. (2010), the ratio 
of neurologists to the general population in African nations is 1:3.4 million. Eleven countries in the 
African continent report no neurologist at all (Siddiqi et al., 2010). The ratio of neurologists to the 
population is 1:26 000 in the United States of America (Siddiqi et al., 2010). 
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Many different medical conditions fall within the category of “neurodisability.” Certain of these 
conditions are known to place affected individuals at higher risk of hearing impairment than the 
general population, for example Down’s Syndrome (Abou-Elhamd, EIToukhy & Al-Wadaani, 2013).  
Other neurological disorders may result in a speech and language delay. In order for speech therapy 
to begin for the remediation of this delay, the child’s hearing status should first be established 
(Spivak, 2007). Even a mild hearing loss will affect speech and language development, and any 
hearing loss should be amplified to the best aided condition before speech therapy begins (Spivak, 
2007). 
It has been established above that the earlier a hearing loss is detected and the faster appropriate 
intervention is provided therefore, the fewer adverse effects the hearing loss will have on the child. 
Indeed early intervention in hearing loss can improve the quality of life for the hearing-impaired 
child (Islami et al., 2013). It is therefore vital that the hearing status of these children with 
neurological disorders be established, with as little delay as possible. These children, however, owing 
to their neurological disorders, struggle with conventional hearing testing and thus require objective 
testing such as the Auditory Brainstem Response (ABR) test (Swanepoel & Ebrahim, 2009). Objective 
testing in audiology is defined as those tests which supplement information obtained in the case 
history and behavioural tests, and make it possible to assess those patients unable to respond 
appropriately in behavioural testing (Gelfand, 2009). 
 
The Burden of Disease 
 
The term “neurological disease” comprises many heterogeneous conditions with different causes 
(Valente, Ferraris & Dallapiccola, 2008). Hearing loss is associated with certain of these conditions 
(Northern & Downs, 2002). It is for this reason, and the fact that the disorders chosen place a large 
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burden on the healthcare system in South Africa that the following neurological disorders were 
identified for the focus of this study.  
South Africa has the largest paediatric epidemic of Human Immunodeficiency Virus/ Acquired 
Immunodeficiency Syndrome (HIV/AIDS), or Retroviral Disease (RVD) in the world (Fatti, Bock, 
Grimwood & Eley, 2010). Of the 33 million HIV-infected individuals worldwide, 35 % reside in 
Southern Africa (Shisana et al., 2009). In 2007, 2.7 million people became infected with HIV 
worldwide, 1.9 million of which reside in Southern Africa (Shisana et al., 2009). The Joint United 
Nations Programme on HIV/AIDS (UNAIDS) has defined the HIV/AIDS epidemic in South Africa as a 
“hyper-endemic epidemic” owing to the fact that 15 % of the population aged between 15 and 49 
years were infected with the virus (Shisana et al., 2009). 
According to Statistics South Africa, an estimated 5.26 million people are living with HIV/AIDS in 
South Africa in 2013 (Statistics South Africa, 2013). In May 2013 it was estimated that 10 383 746 
people residing in South Africa are under 9 years of age (Statistics South Africa, 2013). An HIV Survey 
conducted in 2008 found that 2.5 % of children in South Africa aged 2 to 14 years were HIV-infected 
(Shisana et al., 2009). Therefore, applying this statistic to the population estimate of 2013, it can be 
estimated that there are 259 594 children under the age of 9 years in South Africa living with 
HIV/AIDS. 
According to the guidelines in Paediatric Neurology and Child Development Services in South Africa 
(Department of Health, 2003), conditions such as HIV/AIDS and Tuberculosis place an increased 
burden of disease in the South African public health care system. All children with HIV/AIDS have 
neurodisability (Statistics South Africa, 2003). Therefore it can be surmised that approximately 260 
000 children in South Africa present with a significant neurodisability resulting from HIV/AIDS. 
Cerebral Palsy (CP) is a disorder arising from a permanent, non-progressive insult to the brain that 
results in disturbances in “sensation, perception, cognition, communication and behaviour” (Eunson, 
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2012, p. 361). This group of neurological deficits is the most common cause of motor deficits in 
childhood (Campbell, Hoon & Johnston, 2008) and affects an average of two to two and a half per 
1000 live births worldwide (Eunson, 2012). However, the incidence was found to be higher in South 
Africa, where 10 in 1000 children had cerebral palsy in rural KwaZulu-Natal (Couper, 2002). The 
largest risk factor in causing CP is prematurity. Among preterm infants born before 28 weeks 
gestation the incidence of CP is 100 per 1000 live births, however this decreases to one per 1000 live 
births in children born full term (O’Shea, 2008). 
Autism Spectrum Disorder (ASD) is thought to be a set of neurological disorders resulting in deficits 
of socialization, communication and the presence of rituals and stereotypies (Matson, Beighley & 
Turygin, 2012). Autism is present in some cases as early as birth and infancy (Arieff, Kaur, 
Gameeldien & van der Merwe, 2010). These children will then be unable to form normal social 
relationships, as well as be unable to communicate effectively (Arieff et al., 2010). 
Globally, ASD prevalence has been reported as 11.3 per 1000, or one in 88 children (Autism and 
Developmental Disabilities Monitoring Network Principle Investigators, 2012). This study in the 
United States of America found that the incidence of ASD is higher in the white population (12.0 per 
1000) and more common in males (18.4 per 1000) than in females (four per 1000) (Autism and 
Developmental Disabilities Monitoring Network Principle Investigators, 2012). 
It is predicted by Autism South Africa that one in 150 children born in South Africa are affected with 
Autism, leading to a potential 270 000 children in South Africa living with the disease (Arieff et al., 
2010). This discrepancy in the two values between the two countries could be due in part to cultural 
differences between South Africa and America leading to differences in the number of children 
diagnosed with ASD (Grinker et al., 2012). 
Down’s Syndrome is the most common chromosomal abnormality, occurring in one in 800 births 
globally (Moore, 2008). This syndrome, also known as Trisomy 21, is caused in a vast majority of 
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cases by each cell in the body containing an extra 21st chromosome (Pitetti, Baynard & Agiovlasitis, 
2013). Children with this syndrome have abnormal brain development and function, presenting with 
intellectual impairment (Moore, 2008). 
The prevalence of Down’s Syndrome has increased from nine to 11.8 per 10 000 births in the United 
States of America (Pitetti et al., 2013). This can in part be attributed to the increase in the number of 
mothers bearing children after the age of 35 years (Petetti et al., 2013), as more than half of the 
babies born with Down’s Syndrome are born to mothers above this age (Lampret & Christianson 
2007). The overall prevalence of Down’s Syndrome increases with maternal age, from one per 1000 
births in mothers under the age of 25 to 10 per 1000 births in mothers of 40 years and 70 per 1000 
births in mothers aged 48 years (Lampret & Christianson, 2007). 
In South Africa the prevalence of Down’s Syndrome is slightly higher in rural populations (2.01 per 
1000 live births) than in urban populations (1.8 per 1000 live births) (Lampret & Christianson, 2007). 
This syndrome is therefore as prevalent in South Africa as it is globally, owing to the cause being of a 
genetic nature. 
15 million children are born prematurely (as classified as those children born before 37 weeks 
gestation) across the world each year (Nour, 2012). Sixty percent of these premature births occur in 
Sub-Saharan Africa and South Asia (Nour, 2012). According to Nour (2012), 12.3 % of all births in 
Sub-Saharan Africa are premature. These children are then at risk of developing visual impairment 
and neurodevelopmental effects ranging from learning difficulties to severe cognitive impairments 
to cerebral palsy (Nour, 2012). 
Birth asphyxia, or the impairment of the exchange of oxygen and carbon dioxide (Kurinczuk, White-
Koning & Badawi, 2010), results in approximately 10 % of infants born in America requiring some 
assistance to breathe at birth, 1 % of which require extensive resuscitation (Kattwinkel et al., 2010). 
Of these, three per 1000 survivors in South West London and Western Australia were diagnosed 
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with neonatal encephalopathy, which is the clinical manifestation of disordered brain function in 
neonates (Kurinczuk, et al., 2010). A further one and a half per 1000 infants have hypoxic-ischaemic 
encephalopathy (HIE), or a lack of oxygen in the blood supply, as stated in three studies conducted in 
the United Kingdom, Western Australia and Sweden (Kurinczuk et al., 2010). 
In South African Public Sector Hospitals 35.3 % of neonatal deaths were attributed to hypoxia, and 
was the most common cause of neonatal mortality (Pattinson, Woods, Greenfield & Velaphi, 2005). 
This is higher than the global average of 23 %, which was the third most common cause of neonatal 
death after infections and preterm birth (Buchmann & Velaphi, 2009). Owing to the fact that 
asphyxia leads to neurological disorders, these infants can develop severe consequences such as 
cerebral palsy, epilepsy and other “significant cognitive, developmental and behavioural problems” 
(Kurinczuk et al., 2010, p. 329). 
Hydrocephalus is a blanket term encompassing a variety of “etiological, pathological and age-
dependent conditions” of children with impaired flow of cerebrospinal fluid (Stagno, Navarrete, 
Mirone & Esposito, 2013, p. 17). Children with hydrocephalus present with clinical symptoms, 
enlarged ventricles on neuroimaging, and alterations in cerebrospinal fluid dynamics (García et al., 
2013). Hydrocephalus can be a primary condition, or secondary to conditions such as head trauma, 
meningitis or brain tumours, to name a few (García et al., 2013). In developed countries the 
prevalence rate of hydrocephalus ranges between 0.9 and 1.2 per 1000 (Stagno et al., 2013). 
There is a lack of research on statistics of the number of children born with hydrocephalus in South 
Africa. According to Stagno et al. (2013) the prevalence of hydrocephalus in developing countries will 
be higher than that stated above owing to nutritional deficits, poor treatment of perinatal infections 
and inadequate antenatal diagnosis of the condition. A paper written by Qureshi, Piquer and Young 
(2013) attempted to estimate the burden of disease for hydrocephalus in Africa. These authors 
estimate that of the 250 million people residing in Central, Southern and East Africa, more than 14 
000 will develop hydrocephalus annually within their first year of life (Qureshi et al., 2013). 
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The prevalence of meningitis in children varies depending on the age of the child and on the type of 
meningitis. A study by Levy, de la Rocque and Cohen (2009) estimated an overall incidence of 2.23 
per 100 000 people in France for all ages and strains of meningitis. However, when age is taken into 
account it can be seen that meningitis is far more common in children than in adults (Levy et al., 
2009). The incidence rate in France was found to be 44 per 100 000 for children under the age of 1 
year and 6.9 per 100 000 children aged 1 to 4 years (Levy et al., 2009). 
Tuberculosis Meningitis (TBM) is more prevalent in developing countries owing to the higher 
prevalence of tuberculosis in these nations (Principi & Esposito, 2012). The neurological disability 
resulting from TBM will depend on the level of obstruction of the cerebrospinal fluid from the 
reaction to the tuberculosis bacteria (Dekker et al., 2011). More than half of this population will 
present with severe neurological sequelae (Principi & Esposito, 2012). In the Western Cape province 
of South Africa, the incidence of TBM is seemingly age-dependent, as there are approximately 31.5 
children per 100 000 under one year of age affected with TBM, and 0.7 per 100 000 of children 
between the ages of 10 years and 14 years (Dekker et al., 2011). TBM is the most common bacterial 
meningitis in children in the Western Cape (Dekker et al., 2011). 
In view of pneumococcal meningitis, the incidence appears to remain stable across age groups below 
17 years of age in HIV uninfected children (Nunes et al., 2011). Pneumococcal meningitis is defined 
as the identification of pneumococcus in a sterile site, such as cerebrospinal fluid (Nunes et al., 
2011). The incidence of pneumococcal meningitis was reported to range between 28.9 and 39.6 
cases per 100 000 children under the age of 18 years in South Africa (Nunes et al., 2011). 
It can thus be seen in the above review that prevalence and incidence rates of neurological disorders 
in the paediatric population vary widely between studies, and that there is a general paucity of 
literature on these conditions, especially in South Africa. It is especially difficult to find information 
on the number of children with these conditions, and how this changes during childhood. This 
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dearth of published evidence within this context includes that of published research on hearing 
function in this population. 
 
Hearing Function and Neurological Disorders 
Studies have shown that hearing loss is higher in the HIV-infected paediatric population than in the 
general paediatric population. Laughton, Cornell, Boivin and Van Rie (2013) state that 20 % of HIV-
infected children in high income countries and 38 % in lower income countries presented with a 
hearing loss. This is higher than the incidence of three per 1000 births in the general paediatric 
population stated above. 
In poorer resourced areas these hearing deficits were found to be largely conductive hearing loss as 
a result of chronic suppurative otitis media (CSOM) (Laughton et al., 2013). This differed from higher 
resourced areas, where the hearing losses found were mainly sensorineural in nature (Laughton et 
al., 2013). Hearing impairment for this HIV positive population has been linked to both a low CD4 
count and a history of AIDS-defining illness (Laughton et al., 2013). However, this may be 
compounded by the fact that the global burden of disease for CSOM lies in Africa, South-East Asia 
and the Western Pacific (Mahadevan et al., 2012), thus more children in these countries will present 
with a conductive hearing loss, including those children encompassing the HIV positive population. 
Children with Down’s Syndrome present a special case in terms of audiology. Hearing loss is more 
common in children with Down’s Syndrome than in those affected by other developmental 
disabilities and in healthy children (Abou-Elhamd et al., 2013). Age-related sensorineural hearing loss 
(SNHL) occurs approximately 30 to 40 years earlier in individuals with Down’s Syndrome (Malt, et al., 
2013). This population was found to be 75 % more at risk of developing a hearing loss in America 
(Pitetti et al., 2013). 
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Children with Down’s Syndrome have narrow ear canals (Malt et al., 2013), and Eustachian tube 
dysfunction (Austeng et al., 2013). This most likely stems from muscle hypertrophy and hypertrophy 
of the mid-face that are characteristic of the syndrome (Austeng et al., 2013). As a result of these 
abnormalities, there is insufficient ventilation in the middle ear and stagnation of fluid, leading to an 
increase in the number of cases of CSOM seen in children with Down’s Syndrome (Austeng et al., 
2013). CSOM is significantly related with hearing loss, thus hearing loss is more common in children 
with Down’s Syndrome than those without (Austeng et al., 2013). 
In Utah, in the United States of America, 46.1 % of children with Down’s Syndrome presented with a 
hearing loss in a study by Park, Wilson, Stevens, Harward and Hohler (2011). Of these children with a 
hearing loss, 88.2 % were diagnosed with a conductive hearing loss, 3.9. % had a SNHL and 2 % had a 
mixed hearing loss (Park et al., 2011). 
Studies conducted in Erie in America have shown that 100 % of children with Autistic Spectrum 
Disorder will manifest auditory-related dysfunction of some level (Kulesza, Lukose & Stevens, 2010). 
These dysfunctions can range from hyperacusis (increased sensitivity to sound), delayed cortical 
responses to low frequency sounds, disrupted encoding of simple sounds, difficulty listening in noisy 
environments, to deafness (Kulesza et al., 2010). 
Children with CP can have accompanying hearing loss (Rosenbaum, Paneth, Leviton, Goldstein & 
Bax, 2007). This can be any amount of decibel loss. It is therefore recommended that the hearing of 
every child with CP be assessed and remediated so as to provide the child with the best access to 
sound (Rosenbaum et al., 2007). 
Eleven percent of children with CP in Europe have concomitant visual impairments (O’Shea, 2008), 
thus assessment and intervention of hearing loss becomes more important for these children, who 
will rely on information from the hearing modality to compensate for visual deficits. Identification of 
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concomitant problems in children with CP improves the quality of life and helps to structure the 
individualized management plan more effectively (Campbell et al., 2008). 
Of the infants who have birth asphyxia, approximately 3 % present with a mild hearing loss, and a 
further 3 % present with a severe hearing loss worldwide (Berke, 2010). Therefore, these children 
will require auditory testing in order to diagnose and provide intervention for the hearing loss. 
Similarly, between 5 to 10 % of premature infants globally are diagnosed with a hearing loss of some 
degree (Nour, 2012). In a study by Moore et al. (2012), 0.2 % of infants born before 27 weeks 
gestation in England were diagnosed with a profound hearing loss. Twenty five percent of this 
worldwide premature population will also develop a visual impairment (Nour, 2012), thus hearing 
will be very important in this population. 
Hydrocephalus is often associated with hearing loss. According to Spirakis & Hurley (2003), 83 % of 
the children in their study conducted in Tampa, Florida, had a unilateral high-frequency cochlear 
hearing loss on the side of the shunt. Therefore, these children require hearing testing. 
Dixon and Jones (2012) more recently found in Kentucky in America that increased cranial pressure 
can result in a bilateral SNHL as a result of the pressure limiting the transmission of sound through 
the cochlear aqueduct. They found that this hearing loss improved with surgery to decrease cranial 
pressure, and thus recommend that every child with hydrocephalus has a hearing test (Dixon & 
Jones, 2012). 
Karanja, Oburra, Masinde and Wamalwa (2013) found that among a cohort of meningitic children in 
Kenya, 43.4 % of the sample presented with a SNHL post meningitis, of which 26.5 % presented with 
a mild to moderate hearing loss, and 16.8 % with a severe to profound hearing loss. 
It can therefore be seen that hearing loss is more prevalent in children with the above neurological 
disorders than it is in the typical paediatric population. This therefore emphasizes the need for 
hearing testing in neurologically-compromised children. 
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Assessing Hearing Function in Children 
 
When testing hearing in children, it is preferable to utilize the cross-check principle whereby a 
variety of tests are utilized and the results compared in order to make a final diagnosis (Madell & 
Flexer, 2008). According to the HPCSA (2012), all students of Audiology should be competent in 
testing the hearing function of children in order to graduate the Degree. 
For children less than 6 months it is recommended to rely mainly on objective measures of hearing, 
such as the ABR test (Madell & Flexer, 2008). Behavioural observation audiometry in this population 
can be attempted, for example observing if the child’s sucking becomes faster in response to sound, 
however this is considered to be overall unreliable (Delaroche, Gavilan-Cellie, Maurice-Tison, 
Kpozehouen & Dauman, 2011). 
Behavioural testing of hearing is the gold-standard of obtaining hearing thresholds (Delaroche et al., 
2011). Behavioural audiometry allows threshold estimation across the entire frequency range for 
both air and bone conduction, which is essential information for speech and language development 
(Delaroche et al., 2011). Behavioural audiometry also provides an estimate of the entire auditory 
system from the outer ear to the auditory cortex, thus providing information on cognitive 
development (Delaroche et al., 2011). Even for children with complex needs, behavioural 
evaluations of hearing are preferable (Hall & Bondurant, 2009). 
Once the child has achieved head control and has reached the developmental age to search for the 
origin of the sound, hearing can be tested behaviourally through visual reinforcement audiometry 
(VRA) (Proops & Acharya, 2009). This involves presenting a sound to the child through headphones, 
insert earphones or speakers and reinforcing positive responses by illuminating toys in a glass-
fronted box (Proops & Acharya, 2009). Children able to follow simple commands, usually from 2 or 3 
years of age can have their hearing tested through conditioned play audiometry (CPA) (Proops & 
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Acharya, 2009). In this test children are trained through repetition to perform a task each time they 
hear a sound, for example throwing a block into a bucket (Proops & Acharya, 2009).  
However, according to Jerger and Hayes (1976), behavioural audiometry alone is not enough as the 
results obtained can be misleading and lead to misdiagnosis. Therefore a test battery approach is 
necessary (Madell & Flexer, 2008). This involves selecting multiple tests that both corroborate the 
results of previous testing, as well as provide information on different parts of the auditory pathway. 
By utilizing the test battery approach conclusions are not drawn from a single test and multiple 
pathologies can be identified (Madell & Flexer, 2008). This test battery approach is reportedly 20% 
better at diagnosing hearing loss than using a single test (Diefendorf & Wynne, 2004). 
 
Assessing Hearing in Special Needs Populations  
 
The developmental age of the child will have an impact on the success of the behavioural 
audiometry attempt (Diefendorf & Gravel, 2000). For children with special needs, certain 
adaptations can be made to the test battery and the tasks to try and accommodate for their needs 
(Madell, 2008; Shoup & Roeser, 2007). Positioning, test stimuli and the required response can be 
altered, based on estimations of the motor and play skills of the child (Madell, 2008). 
Children with neurological disorders are a population for which behavioural responses are difficult to 
ascertain (Madell, 2008). The responses may be much slower, they may fatigue quickly, or they may 
habituate to test stimuli and reinforcers faster than those children without neurological disorders 
(Madell, 2008). These children may also become fearful of the reinforcer or refuse headphones 
(Madell, 2008). 
The behaviour of this population in the test may be so erratic that standard techniques cannot be 
utilized to test them (Northern & Downs, 2002). According to Proops & Acharya (2009), children 
26 | P a g e  
 
such as those diagnosed with ASD may not respond reliably in behavioural testing, and would thus 
require objective testing to make a definitive diagnosis. The ABR, as found in Portugal, is often the 
only test that offers information about the hearing status of these children as a result of their “lack 
of cooperation, attention deficit and cognitive dysfunction” (Coutinho, Rocha & Carmo Santos, 2002, 
p. 84). 
According to the American Speech and Hearing Association (ASHA), for those children with 
developmental disabilities, the diagnosis of hearing loss should rely primarily on objective testing, 
such as the ABR, to evaluate hearing function (Purdy & Kelly, 2008). This should be done through 
obtaining frequency-specific information so that the audiogram can be estimated (Purdy & Kelly, 
2008). However, immittance audiometry, OAEs, a comprehensive case history, behavioural 
observation, and functional hearing measures should also all be conducted or at least attempted in 
order to supplement the ABR results (Purdy & Kelly, 2008; Lancioni et al., 1985). 
 
The ABR Test 
 
The ABR is a brainstem auditory evoked potential that allows “neurophysiologic analysis of the 
auditory pathways between the inner ear and the upper brainstem” (Sleifer et al., 2007, p. 2). An 
ABR is an electrophysiological test representing the “summed auditory neural activity” (Purdy & 
Kelly, 2008, p. 132). It tests the audiological pathway from the eighth cranial nerve to the midbrain in 
the brainstem (Newman & Sandridge, 2007). 
Surface electrodes are placed onto the forehead and on the mastoid behind each ear so that 
electrical responses to the acoustic signal placed into the patient’s ear can be measured (Newman & 
Sandridge, 2007). The response is a summation of the neural activity along the pathway and is 
described in terms of latency (time) and amplitude (voltage) (Purdy & Kelly, 2008). 
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The ABR response is measured within the first 10 msec after the presentation of the stimulus 
(Arnold, 2007). Through using both clicks and tone-burst stimuli the neural integrity of the auditory 
pathway from the vestibulocochlear (VIIIth cranial) nerve to the midbrain can be examined, and the 
hearing threshold can be estimated (Arnold, 2007). 
The click ABR is an ABR tested using a brief duration and rapid onset click stimulus (Purdy & Kelly, 
2008). The click is comprised of many frequencies, and is thus considered a broadband stimulus 
(Crumley, 2011). This makes it possible to record an ABR on a patient with a significant hearing loss, 
as long as there are areas of hearing ability in the frequency range of 2 kHz – 4 kHz (Crumley, 2011). 
However, this can give a false impression of the patient’s hearing, as there is a possibility of a child 
with a significant hearing loss in the higher frequencies showing responses in the ABR with a 
broadband stimulus if there is useable hearing in the low frequencies (Ferm, Lightfoot & Stevens, 
2013). It is for this reason that there has been a move away from broadband stimuli in testing the 
hearing status of newborns (Ferm et al., 2013). 
Tone-burst ABR, alternatively, utilizes tone-burst stimuli that allow for frequency-specific 
assessment (Crumley, 2011).  Through utilizing tone-burst ABR, a clinician is able to isolate low-
frequency versus high-frequency hearing loss (Crumley, 2011), and reliably predict the pure-tone 
audiogram (Purdy & Kelly, 2008). However, a disadvantage is that the amplitude of the tone-burst 
stimuli is typically 70 % smaller compared to that of click stimuli, thus the testing time is twice as 
long in order to overcome this problem and allow for a more robust response (Ferm et al., 2013). 
Both of these stimuli are important in audiological practice. Currently, the click ABR has an 
important role to play in the diagnosis of ANSD, thus the accepted practice is to utilize broadband 
stimuli for this testing, and tone-burst stimuli to acquire information about the child’s audiological 
abilities (Purdy & Kelly, 2008). 
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Similarly, the latency of the ABR response has been shown to be age-dependent (Coenraad, 
Immerzeel, Hoeve & Goedegebure, 2010). The latency of waves III and V decreases with age until 
two years, however the latency of wave I is seemingly stable from birth (Coenraad et al., 2010). This 
has been attributed to a central maturation effect as a result of the process of myelination in the 
first two years of life (Coenraad et al., 2010). 
Although tone-burst ABR can predict a child’s hearing ability, the relationship between the results of 
tone-burst ABR and pure tone audiometry for the same child is not exact (Purdy & Kelly, 2008). It is 
for this reason that correction factors are necessary that allow for the creation of an estimated 
audiogram based on the ABR results (Purdy & Kelly, 2008). Tables based on regression equations of a 
study in 1995 are commonly used for this purpose (Purdy & Kelly, 2008); however each clinic is 
encouraged to establish their own clinical norms based on the testing system utilized and the patient 
population utilizing the services (Arnold, 2007). 
Bocskai, Németh, Bogár and Pytel (2013) studied the effects of sedation on the ABR. Although the 
ABR tracings for children under sedation contained less artefacts than awake tracings, this study 
found that sedatives can have negative side-effects in certain children (Bocskai et al., 2013). These 
side-effects can include agitation, nausea, vomiting, coughing, low blood pressure, breathing 
difficulties and oxygen desaturation (Bocskai et al., 2013). 
The ABR has been shown to be a reliable and accurate manner with which to assess the hearing 
status of the paediatric population (Dornan, Fligor, Whittemore & Zhou, 2011). In order to optimize 
the efficiency of the test, different testing protocols can be used so that the maximum information 
regarding the child’s hearing status is obtained in the shortest possible time (Purdy & Kelly, 2008). In 
this manner, should testing have to be aborted owing to the child awaking, a clinical decision should 
still be possible with the information available (Purdy & Kelly, 2008). Many different suggested 
protocols exist in order to achieve this aim (Purdy & Kelly, 2008). 
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ABR in Neurologically Compromised Children 
 
For children with special needs, the primary goal is to rule out bilateral hearing loss of a mild degree 
or worse (Diefendorf & Wynne, 2004). This, as shown above, is generally done through ABR testing. 
Studies have shown that children affected with neurological disorders have ABRs that differ from 
those with a normal neurological status (Kwon, Kim, Choe, Ko & Park, 2007). These differences 
therefore need to be taken into account when conducting hearing testing in these children. 
According to the Journal of Korean Medical Science, the ABR for children in South Korea on the 
Autistic Spectrum typically presents with prolonged latency of wave V, as well as the Interpeak 
Latencies I-V and III-V (Kwon et al., 2007). This can indicate that children with Autistic Spectrum 
Disorder have an immaturity or dysfunction in the Central Nervous System (Kwon et al., 2007). 
Kulesza et al. (2010) found that children on the Autistic Spectrum in Erie in the United States of 
America have immature brainstem anatomy, namely the Superior Olivary Complex. This 
dysmorphology in auditory brainstem nuclei results in auditory dysfunction mentioned above 
ranging from hyperacusis to deafness (Kulesza et al., 2010). 
This study goes further to state that these structural deficits are present at birth, thus ASD could be 
diagnosed earlier through the use of ABR (Kulesza et al., 2010). However, these structural 
abnormalities vary within individuals diagnosed with ASD, resulting in diversity and challenges in 
diagnosing ASD (Kulesza et al., 2010). They purport that as ASD is a continuum depending on the 
extent of neurological dysfunction, auditory deficits observed will depend on the extent of 
dysmorphology in the auditory brainstem with deafness being the most severe (Kulesza et al., 2010). 
ABR therefore cannot be the sole manner of diagnosis (Kulesza et al., 2010). 
In a population of children with Down’s Syndrome in Poland, the ABR presented with short latencies 
and lower amplitudes, possibly owing to the accelerated maturation of the nervous system or 
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disturbances in the nervous system (Kręcicki, Zalesska-Kręcicka, Kubiak & Gawron, 2005). Peaks II, 
III, IV and V were found to have shorter absolute latencies, which leads to short I-II and I-III Interpeak 
Intervals (Kręcicki et al., 2005). This was found for intensities of at least 45 dB above the patient’s 
threshold. The shorter latencies and amplitudes could also be attributed to the deficient cerebral 
organization and information processing common of these children (Kręcicki et al., 2005). 
However, when Kuhn et al. (2013) conducted ABR testing on mice with Trisomy 21 in the United 
Kingdom, they found that waveform amplitudes and latencies and hearing levels for these mice 
compared to normal controls, and no abnormalities were exhibited in the ABR. This indicates that 
clarity on this population is needed, as definitive results on how Down’s Syndrome affects the ABR 
are not available at present. 
Jiang, Brosi, Shao and Wilkinson (2008) studied ABR tracings in infants in Shanghai, China and the 
United Kingdom with severe perinatal asphyxia. They found that during the first month of life the 
amplitudes of all waves, particularly wave V, were reduced (Jiang et al., 2008). This reflects the 
decreased number of cells in the response, resulting from neuronal impairment or death in the 
brainstem following asphyxia (Jiang et al., 2008). 
The reduction in amplitudes continued well into the first month of life (Jiang et al., 2008). This 
prolonged decrease indicates that the neuronal impairment is therefore not likely to recover quickly 
(Jiang et al., 2008). Some cells may not only die at the time of the asphyxia, but continue to die 
hours and days after the event (Jiang et al., 2008). 
Development of the auditory system is postulated, based on a cohort of Brazilian children, to occur 
in two phases (Casali & dos Santos, 2010). The first phase occurs in utero whereby the peripheral 
auditory system is developed by the 6th month of gestation (Casali & dos Santos, 2010). The second 
phase occurs after birth until 18 months of age and comprises of the maturity of the central auditory 
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pathways up to the brainstem (Casali & dos Santos, 2010). This is important to take into account in 
testing premature infants. 
Absolute latencies of all waves are increased in neonates in comparison to adult values, possibly as a 
result of the immature auditory system not having undergone myelination, thereby increasing the 
conduction time (Casali & dos Santos, 2010). The absolute latency of Wave I decreases with an 
increase in gestational age and reaches adult values within the first few weeks of life, whereas the 
values of Waves III and V only reach adult latencies by two years of age (Casali & dos Santos, 2010). 
Therefore taking into account the child’s gestational age is important in testing premature infants 
with ABR (Casali & dos Santos, 2010). 
The only study conducted on ABR results in patients with hydrocephalus dates back to 1984. No 
recent studies could be found on the subject. In this study, 88 % of the hydrocephalic cohort in 
Chicago, America, indicated some abnormalities on ABR, ranging from delayed wave latencies to 
poor waveform morphology to raised hearing thresholds (Kraus, Özdamar, Heydemann, Stein & 
Reed, 1984). 
Children in Guangxi Zhuang National Autonomous Region in China with CP presented with prolonged 
latencies when compared to neurologically uncompromised peers (Zhu, Wang & Liang, 2006). 
However there is a dearth of studies in this population, possibly owing to the vast differences in the 
hearing function of these children. 
In a study by Topcu et al. (2002) in Diyarbakir, Turkey, 24 % of children with meningitis presented 
with abnormal ABR results. Interpeak latencies were increased for I – V and I – III, and 14.8 % 
presented with no visible waveforms at the maximum output of the equipment (Topcu et al., 2002). 
These differences are important to keep in mind in order to decrease the chance of misdiagnosis in 
this population. 
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The above information on how neurological disability affects the ABR was extremely difficult to 
locate. Most studies were based on a small sample size, and are out-dated. Worldwide, there is a 
severe lack of literature on how the ABR is affected by certain medical (especially neurological) 
conditions in children. For some of these conditions, such as Down’s Syndrome and RVD, no 
information is available on how these diagnoses affect ABR results. Therefore, this is an area 
requiring further research; hence the importance of this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 | P a g e  
 
2. Methodology 
 
2.1. Aims and Objectives 
 
Primary Aim of the Study: 
To describe the hearing test results in a group of neurologically compromised children. 
 
Study Objectives: 
1. To describe the audiological ABR findings in order to determine hearing function in this group.  
2. To establish a relationship between audiological ABR findings and behavioural audiometry findings 
where these exist. 
 
2.2. Research Design 
 
A descriptive Retrospective Review of patient records was conducted on 40 audiological records of 
children between the ages of 5 months to 10 years from the Speech Therapy and Audiology 
Department at Chris Hani Baragwanath Academic Hospital. 
In qualitative research a naturalistic approach is used whereby the aim is to understand phenomena 
in context-specific settings (Golafshani, 2003). This study aimed to describe the hearing status of a 
neurologically disordered cohort of children whose test battery included the ABR at the Audiology 
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Department of Chris Hani Baragwanath Academic Hospital. Traditionally, qualitative research aims 
for “illumination, understanding, and extrapolation to similar situations” (Golafshani, 2003, p. 600). 
Audiological records of patients fitting the inclusion criteria were drawn from the Departmental 
Archive. These records were of children assessed between the months of September 2010 and 
February 2012. Results of Neurologically Typical children were not analyzed. Results of children 
diagnosed with one or more of the following disorders were included in this study: 
 Cerebral Palsy 
 Developmental Delay 
 HIV/AIDS 
 Hydrocephalus 
 Down’s Syndrome 
 Birth Asphyxia 
 Autism Spectrum Disorder 
 Meningitis 
 
These pathologies were chosen, as according to the earlier described Burden of Disease, 
neurological disorders account for 10 % of children in low-resourced areas (Patel, Goel & Desai, 
2009). These conditions are the most prevalently seen in children attending health care institutions 
in Soweto. For the purposes of hydrocephalus and CP, these blanket terms were utilized as this is 
what was recorded on the patient record. The subcategories of these pathologies were not 
recorded, thus it remains unknown as to with which type of hydrocephalus and CP the patient was 
diagnosed by the medical practitioner. 
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Testing results for behavioural testing attempts (if available) were also included in the data 
collection. The most recent test results were utilized for comparison to those results obtained 
objectively via Tone-Burst ABR. 
 
Equipment: The records of the patients’ ABR tests were drawn from the Resource Room of the 
Audiology Department. A laptop containing an Excel spreadsheet was utilized for data capturing and 
data management. 
 
2.3. Participants 
 
Participants: Forty audiological files and records of infants and children between the ages of 5 
months and 10 years diagnosed with one of the above neurological disorders were included in this 
study. These records were of patients tested at the Audiology Department at Chris Hani 
Baragwanath Academic Hospital using the Eclipse Auditory Evoked Potential Machine during the 
months of September 2010 and February 2012. All children in this study were tested under natural 
sleep, i.e. without sedation. Owing to the side-effects outlined above, sedation is only used in rare 
cases in CHBAH, and thus this population would be too small in number to analyze for the purpose 
of this study. The patients had been diagnosed by an appropriate medical practitioner as presenting 
with one or more of these neurological disorders. 
Results of behavioural testing attempted for these children were drawn. The most recent test results 
were utilized for those with multiple attempts. If the results of the behavioural attempts were 
inconclusive, this was documented. For those children for whom no results were available, “no 
results” was documented for the behavioural section. 
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Recruitment: Patient records were recruited from the archive at Chris Hani Baragwanath Academic 
Hospital. The first 40 records of patients meeting both the age and diagnostic criteria were included 
in the sample. 
 
2.4. Test Protocol 
 
All patients in this study were tested using the CHBAH ABR protocol, as indicated in the patient 
records. The following describes the manner in which all patients were tested. The ABR results 
consisted of Tone Burst thresholds obtained at one or more of the following frequencies: 500 Hz, 1 
kHz, 2 kHz and 4 kHz. Threshold for at least one frequency in each ear was documented during 
testing so as to obtain ear-specific information regarding both ears. 
Patients will initially have been scrubbed using Webcol alcohol swabs and NuPrep Skin Preparation 
Paste on the electrode sites. Electrodes were placed on the mastoid processes behind both the left 
and the right ears, high on the forehead in the midline (vertex) and directly below this between the 
eyes (ground). Impedance was less than 5Ω across all electrode sites for testing to commence. The 
EEG was set to 20 μV, with minimal rejects. All wave tracings with a large number of rejects and low 
wave reproducibility were deleted, and another tracing was conducted at that intensity. 
The Tone Burst ABR was conducted at 44.1 cps, on an alternating polarity. Testing began at 60 
dBnHL at 4kHz, and Wave V was traced until its disappearance. If Wave V could be clearly seen, the 
intensity was reduced by 10 dBnHL. If Wave V could not be seen, the intensity was increased by 5 
dBnHL until the waveform was visible. A second tracing was conducted at the lowest intensity at 
which wave V could be seen to ensure that the downward deflection is Wave V. 
Correction factors based on the transducer, patient age and frequency (see Appendix 2) were then 
applied in order to convert this result to a hearing threshold estimate in dBeHL. Should no waveform 
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be visible at the maximum intensity of the system, “NR” (or “No Response”) would be documented, 
followed by the maximum intensity at which the testing was conducted. 
The behavioural test battery began with otoscopy and immittance testing (tympanometry and 
acoustic reflexes) in order to gain information about the child’s outer and middle ear status. 
Depending on the child’s age and developmental and physical capabilities, either Visual 
Reinforcement Audiometry (VRA) or Conditioned Play Audiometry (CPA) was then attempted under 
headphones. Testing began at 1 kHz at 60 dBHL where the child was familiarized with the task, and 
the threshold for each frequency was documented as the lowest level at which the patient gave two 
reliable conditioned responses to the sound (either a head turn or placing a toy in a bucket) 
If the patient was averse to the headphones, testing in free field was attempted. Sound was 
presented through one of two speakers, and the same conditioned response would have been 
expected. Thresholds for this test are not ear-specific as the patient is listening with both ears 
simultaneously (Delaroche, Thiebaut & Dauman, 2004). Results of free-field testing pertain to at 
least one cochlea, but results cannot be documented per ear (DeConde Johnson & Seaton, 2011), 
therefore results were not recorded per ear for free-field testing. The better hearing ear will 
respond; therefore if the hearing loss is asymmetrical the worse ear may be misdiagnosed. 
 
2.5. Data Analysis 
 
Each patient’s hearing status was described per ear based on the documented tone-burst ABR 
thresholds. The classification by Gelfand (2009) was utilized to describe the degree of hearing loss 
for each ear tested (see Appendix 1). This description was also done for those patients for whom 
behavioural results under headphones were available. For those patients tested behaviourally in 
free-field the overall hearing status was described, and one ear was marked as “no results.” 
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Descriptive statistics were conducted by the researcher for each set of objective and behavioural 
results, per ear, for all 40 subjects in terms of incidence and degree of hearing loss, as well as 
comparing ABR and behavioural results within the same ear. The pathologies were then 
documented in terms of occurrence, as well as the hearing results for each of the six main 
pathologies. Patient age was expressed in terms of the average and the standard deviation (in 
months). 
 
2.6. Reliability and Validity 
 
2.6.1. Reliability 
 
Reliability refers to the stability of the test (Carter, Godoy, Marakovitz and Briggs-Gowan, 2009). In 
order for an audiological test to be reliable the test should consist of controlled stimuli in an 
acoustically-controlled environment (Frank & Rosen, 2007). All patients in this study were tested 
using the Interacoustics Eclipse System for ABR testing and a GSI 61 audiometer for behavioural 
testing, both calibrated and serviced annually, thus technical inconsistencies were minimized. Daily 
biologic calibration was conducted by the audiologist before using all equipment as per 
Departmental Protocol, which ensures the accuracy of the equipment (Frank & Rosen, 2007). All 
testing rooms were also sound-treated to reduce noise. 
Owing to the fact that this study is a retrospective record review, controlling patient variables to a 
high degree of reliability could not be ensured. The testing conditions remained the same in each 
test to the best of the tester’s ability. According to Carter et al. (2009), a detailed training manual 
and assessment protocol increases inter-rater reliability. All patients were tested with the same 
protocol, written by the researcher, thus maximizing reliability. Patient and test variables were 
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thought to also be managed by the fact that the behavioural audiometry and ABR testing procedures 
form part of standard audiology practice for qualified audiologists (Kanji, 2010). 
The ABR test has established test-retest reliability (Song, Nicol & Kraus, 2011). Similarly, intra-subject 
reliability is small in that variations in the absolute latency of the click ABR differ very little between 
tests (Song et al., 2011). Therefore, results from the ABR test will give a reliable indication of the 
patient’s hearing abilities. 
 
2.6.2. Validity 
 
Validity refers to the ability of a test to measure what it purports to measure (Carter et al., 2009). 
Validity was enhanced by taking into consideration the effect of patient and environmental factors 
on ABR tracings. According to the ABR protocol utilized at CHBAH, “noisy tracings” (or those tracings 
for which the signal-to-noise ratio is worse than 3:1) are deleted, and another tracing is conducted. 
In this way, the response is replicable, and clearer deductions can be made. 
Panacek (2007) recommends that in order to increase the validity of a retrospective review, 
variables should be defined before data is abstracted. Each patient had been diagnosed with a 
neurological disorder by a relevant professional before their ABR test, and this diagnosis was copied 
from the patient’s hospital file by the tester. Degree of hearing loss was classified for each patient 
according to the classification by Gelfand (2009) (see Appendix 1). In this way the abstraction from 
the data records was consistent (Panacek, 2007). 
Similarly, Panacek (2007) states that a uniform data collection form should be utilized in order to 
enhance the validity of the study. All patient data was captured onto a summary form (see Appendix 
6), thus all data were captured uniformly for each patient. 
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2.6.3. Bias 
 
ABR interpretation is subjective, as the tester has to identify waveforms in order to make a 
diagnosis. In order to reduce bias, the interpretation of the ABR waveforms was taken as written on 
the patient report. The waveforms for each child were interpreted by the tester at the time of the 
test. The diagnosis written on the page was taken, thus results were analyzed by one of five 
audiologists and not just the author. 
 
2.7. Ethical Considerations 
 
 
Permission to review records was obtained from CHBAH hospital management and the Head of 
Department of Speech Therapy and Audiology at CHBAH (see Appendices 3 and 4). Data collection 
only began following permission from the Postgraduate Review Committee, and the Human 
Research Ethics Committee (Medical) at the University of the Witwatersrand. The Ethical Clearance 
Certificate Number M120217 (see Appendix 5) was obtained on 24.02.2012. All of this was in 
accordance with the World Medical Association (WMA) Declaration of Helsinki (2008), which calls for 
all medical research to appear before an Ethics Committee. 
Owing to the fact that it is a retrospective study of patient records, patient consent was not 
obtained. However, these patients attended a teaching and research hospital where records are 
utilized for research purposes. According to the WMA Declaration of Helsinki (2008), no harm should 
come to the patient. All subjects in this study sample attended CHBAH for a hearing test during 
which the patient was not harmed in any way. No additional intervention occurred for the purpose 
of this study. 
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Similarly, the WMA Declaration of Helsinki (2008) states that patient privacy should be ensured, and 
that no personal information should be divulged. A coding system was created whereby patients 
were allocated a number so that no identifying information was utilized.  This ensured 
confidentiality and anonymity of the study sample. Therefore, this study abides by the ethical 
regulations of confidentiality and non-maleficence. 
The WMA Declaration of Helsinki (2008) additionally states that testing should only be conducted by 
appropriately trained personnel. All testing conducted for the patient records was performed by 
audiologists working at CHBAH and registered with the HPCSA to practice audiology. 
Justice is a major consideration in medical ethics (Pratt & Loff, 2011). Justice is defined differently in 
various sources, and consists of ensuring that the research conducted reacts to the health needs and 
priorities of the community or country in which it was conducted, that all benefits are fairly and 
freely available to participants during and after clinical trials, and result in the strengthening of 
ethical research in the community or country of the research participants (Pratt & Loff, 2011). 
This research project adhered to the principle of justice in that, as evident in the literature review 
above, neurological disorders are rife in the paediatric population of South Africa, and thus comprise 
the burden of disease in this population. 
Similarly, all patients had undergone ABR testing, thus no treatment options were withheld and all 
patients received equal opportunities in terms of hearing testing options. By adhering to these 
aspects of justice, this research contributes to an ethically-sound body of medical studies. 
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3. Results 
 
3.1. Demographic Profile 
 
A total of 40 patient files were drawn from the Departmental Archive. All patients resided in the 
catchment area for Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg. The sample 
consisted of 21 males and 19 females. The average age was 28 months, with a standard deviation of 
24 months. The median age was 22 months, and the age range was 5 months to 115 months (9 years 
7 months). 
Results are described per ear for audiological analyses (N = 80), and per participant in analyzing the 
pathologies (N = 40). Certain patients had multiple neurological disabilities. For these patients all 
relevant diagnoses were taken into account in analysis if the disability appeared on the above list of 
neurological disabilities for this study. Eleven children presented with two neurological disabilities 
and five further children had been diagnosed with three of the neurological disabilities included in 
this study. 
 
3.2. Results of the ABR Test 
 
Of the 40 records drawn from the CHBAH Archive, 22 patients (55 %) presented with normal hearing 
bilaterally, ten (25 %) presented with bilateral symmetrical hearing loss, seven (17.5 %) presented 
with an asymmetrical hearing loss, and one patient (2.5 %) was diagnosed with a unilateral hearing 
loss. 
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It can be seen in Table 1 below that 45 of the ears tested (56.2 %) presented with normal hearing. Of 
these 45 ears, 44 (97.7 %) were bilateral and 1 child (2.5 %) presented with a unilateral hearing loss 
with normal hearing in the right ear. Eight ears (10 %) were diagnosed with a profound hearing loss 
in Electrophysiological testing. These results were obtained in five children, three with bilateral 
profound hearing losses and two with unilateral asymmetrical profound hearing losses diagnosed. 
All three children with bilateral profound hearing losses had been diagnosed with cerebral palsy. 
 
DESCRIPTION OF HEARING NUMBER OF EARS 
Normal Hearing 45 
Profound Hearing Loss 8 
Mild Hearing Loss 7 
Moderately-Severe Rising to Mild Hearing Loss 4 
Moderately-Severe Hearing Loss 3 
Mild Sloping to Moderate Hearing Loss 2 
Moderate Sloping to Severe Hearing Loss 2 
Severe Sloping to Profound Hearing Loss 2 
Moderate Hearing Loss 1 
Moderate Rising to Mild Hearing Loss 1 
Moderate Sloping to Moderately-Severe Hearing Loss 1 
Severe Rising to Normal Hearing Loss 1 
Severe Rising to Moderate Hearing Loss 1 
Profound Rising to Moderately-Severe Hearing Loss 1 
Profound Rising to Severe Hearing Loss 1 
Total 80 
Table 1: Table to Show the Description of Hearing Status and the Number of Ears Presenting with 
Each 
 
3.3. Results of Behavioural Testing 
 
Figure 1 below depicts that for 58 out of a total 80 ears (72.5 % of the study sample) no results could 
be obtained with behavioural testing. No results could be obtained bilaterally in 24 children (60 %), 
and unilaterally in 10 children (25 %). Fifty percent (n=11) of the ears for whom behavioural results 
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were available presented with normal hearing. Three of these were children presenting with normal 
hearing in both ears under headphones. Five of these patients were tested in free field, and thus 
have normal hearing in at least one cochlea. Four ears (5 %) presented with a moderate hearing loss. 
A profound hearing loss was diagnosed in three ears (one unilateral and two bilaterally in 1 child), or 
3.75 % of ears tested. Sloping hearing losses were diagnosed in three ears (3.75 %), and a severe-to-
profound hearing loss was diagnosed in free field in at least one cochlea for one patient (1.25 %). 
 
 
Figure 1: Bar Graph to Show the Audiological Results of Behavioural Testing 
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3.4. ABR Compared to Behavioural Testing Results 
 
Of the sample of 80 ears 7.5 % (n=6) were diagnosed with normal hearing in both behavioural and 
objective testing, as depicted in Table 2 below. For 58 ears (72.5 %) no behavioural results were 
obtained. For the remaining 16 ears (20 %) there was a discrepancy between behavioural and 
objective testing. Therefore 92.5 % of the results differed in behavioural and ABR testing, and those 
results that correlated were only in normal hearing ears. 
BEHAVIOURAL TEST ABR TEST NUMBER 
OF EARS 
No Results Normal Hearing 30 
No Results Profound Hearing Loss 8 
No Results Moderately-severe Rising to Mild Hearing Loss 4 
No Results Moderate Sloping to Moderately-Severe Hearing Loss 1 
No Results Moderately-Severe Hearing Loss 3 
No Results Mild Hearing Loss 5 
No Results Moderate Sloping to Severe Hearing Loss 1 
No Results Profound Rising to Severe Hearing Loss 1 
No Results Mild to Moderate Hearing Loss 2 
No Results Severe Rising to Normal Hearing Loss 1 
No Results Severe to Profound Hearing Loss 2 
Normal Hearing Normal Hearing 6 
Normal Hearing Moderate Hearing Loss 1 
Normal Hearing Moderate Sloping to Severe Hearing Loss 1 
Normal Hearing Profound Rising to Moderately-Severe Hearing Loss 1 
Normal Hearing Mild Hearing Loss 1 
Normal Hearing Moderate Rising to Mild Hearing Loss 1 
Moderate Hearing Loss Normal Hearing 4 
Moderately-Severe Rising to Mild 
Hearing Loss 
Normal Hearing 1 
Severe Rising to Moderately-Severe 
Hearing Loss 
Normal Hearing 1 
Severe Sloping to Profound Hearing 
Loss 
Normal Hearing 1 
Profound Rising to Moderately-Severe 
Hearing Loss 
Normal Hearing 1 
Profound Hearing Loss Mild Hearing Loss 1 
Profound Hearing Loss Normal Hearing 1 
Profound Hearing Loss Severe Rising to Moderate Hearing Loss 1 
Total  80 
Table 2: Table to Show the Results of Behavioural Compared to ABR Testing in the Same Ear 
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It can be seen from Figure 2 below that for a majority of ears (72.5 %) no results were obtained 
behaviourally. 37.5 % (n = 30) of these ears, when later tested via ABR, had normal hearing, and 35 
% (n = 28) were diagnosed with a hearing loss on electrophysiological testing. 
For those ears with behavioural results, 7.5 % of ears with a hearing loss diagnosed objectively were 
falsely diagnosed with normal hearing based on behavioural testing. Similarly, 10 % of children with 
normal hearing in ABR were diagnosed with a hearing loss behaviourally. Two and a half percent of 
the sample who had a hearing loss were diagnosed with a hearing loss in behavioural testing, 
however the degree of the loss was worse in behavioural testing than the results obtained 
objectively.  
 
 
Figure 2: Pie Chart to Show to Compare ABR Audiological Results with those obtained Behaviourally 
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3.5. Results per Pathology 
 
Figure 3 below indicates the number of children presenting with each diagnosis. The two most 
common diagnoses in the sample were prematurity (27.5 % of sample) and cerebral palsy (25 % of 
sample). Hydrocephalus (17.5 %), Down’s Syndrome (12.5 %), meningitis (12.5 %) and birth asphyxia 
(10 %) were also common in the sample, yielding a combined 52.5 % of the sample. The rest of the 
pathologies were less common, only diagnosed in 1 or 2 patients each. Only two of the study sample 
(5 %) presented as RVD positive. 
 
Figure 3: Pie Chart to Show the Pathologies Represented in the Sample 
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Figure 4 below indicates the number of hearing losses diagnosed per pathology. More hearing losses 
were diagnosed in ABR testing, with a total of 22 losses (55 %) diagnosed on ABR testing for these 
pathologies, and only six (15 %) on behavioural testing for the same subset of the sample. A majority 
of patients diagnosed with Cerebral Palsy, Down’s Syndrome, prematurity and RVD presented with a 
hearing loss, as 19 patients out of a combined 28 patients with these conditions (67.8 %) were 
diagnosed with a hearing loss objectively. 
 
 
Figure 4: Bar Chart to Show the Number of Hearing Losses Diagnosed on ABR and Behavioural 
Testing for the 6 Main Pathologies. 
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 ABR BEHAVIOURAL TOTAL WITH PATHOLOGY 
Cerebral Palsy with Normal Hearing 3 1 10 
Down’s Syndrome with Normal Hearing 1 0 5 
Prematurity with Normal Hearing 5 4 11 
Hydrocephalus with Normal Hearing 6 1 7 
Meningitis with Normal Hearing 3 1 5 
RVD with Normal Hearing 0 0 2 
Table 3: Table to Show the Number of Children Presenting with Normal Hearing in Behavioural and 
ABR Testing per Pathology 
 
Table 3 also depicts that a majority of children with hydrocephalus (85.7 %) and with meningitis (60 
%) were diagnosed with normal hearing on ABR testing. However, as seen in Figure 4 above, most of 
the children with CP, Down’s Syndrome, prematurity and RVD were diagnosed with a hearing loss on 
ABR testing. 
 
 NUMBER WITH NO RESULTS TOTAL PERCENTAGE of SAMPLE (%) 
Cerebral Palsy 7 10 70 
Down’s Syndrome 5 5 100 
Prematurity 6 11 54.6 
Hydrocephalus 4 7 57.1 
Meningitis 3 5 60 
RVD 2 2 100 
Table 4: Table to Show the Number and Percentage of Patients for Whom No Results were Obtained 
Behaviourally 
 
Table 4 above indicates that for these six pathologies, a majority of the sample could not be tested 
behaviourally. Results could not be obtained for all the patients in the sample diagnosed with 
Down’s Syndrome and with RVD. Seventy percent of children with CP could not undergo behavioural 
testing reliably, as well as 60 % of those with meningitis, 57.1 % with hydrocephalus and 54.6 % with 
prematurity. 
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No statistical hypothesis testing could be conducted on the data owing to the lack of complete 
behavioural results in this population and the fact that within the subset of patients with normal 
hearing, some levels were screened and some levels were definite thresholds below which the 
patient will not hear. These inconsistencies led to too many extraneous variables for statistical 
analysis. 
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4. Discussion 
 
Diagnosis of Hearing Status 
 
An objective test is described as a test of hearing “without the patient’s active participation in the 
test” (Northern & Downs, 2002, p. 209). According to Diefendorf and Gravel (2000), the 
responsiveness of the developmentally delayed child is associated with their developmental level, 
leading to both high false positive and false negative results in behavioural testing. In this study, of 
the ears with behavioural results, half were diagnosed with a hearing loss, whereas only 44 % of the 
entire sample presented with a hearing loss on ABR testing (see Table 1). This indicates higher false 
positive rates for behavioural testing. Similarly, as seen in Table 2, 11 ears presented with a hearing 
loss of worse degree on behavioural testing than on ABR testing, emphasizing the high false positive 
rate for behavioural testing. Five ears were diagnosed with normal hearing on behavioural testing; 
however these ears were diagnosed with a hearing loss on ABR testing (see Figure 2). This indicates 
a false negative rate in behavioural testing, and is in agreement with the finding of Diefendorf and 
Gravel (2000) of both high false negative and false positive results stated previously. 
In this study population a total of 72.5% (n = 58) of the sample could not be tested behaviourally (as 
seen in Figure 1). More hearing losses were diagnosed in ABR than on behavioural testing. Thirty five 
ears were diagnosed with a hearing loss objectively versus 11 behaviourally. This indicates that most 
hearing losses are detected in a test where a response is not expected from the patient, and is in 
fitting with the finding of Swanepoel and Ebrahim (2009) that electrophysiological testing, via ABR or 
ASSR, would be necessary for those populations who are unable to cooperate or respond in 
behavioural testing. 
Two and a half percent of ears (n=2) presented with a hearing loss on both behavioural testing and 
objective testing (see Figure 2 above). However the degree of hearing loss differed in the two tests 
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in that both of these children presented with a profound hearing loss on behavioural testing, 
however the hearing was found to be better on ABR testing (one with a mild hearing loss, and the 
other with a severe rising to moderate hearing loss) in both children. The two children seemingly did 
not show any response at high sound intensities tested, thus leading the tester to deduce that the 
child has a profound hearing loss. The child may have heard the sound, but may have not 
understood the task, or the conditioned response expected from them may have been too difficult 
for their developmental level, causing the child to not respond. These children, should the 
behavioural results indicating a profound hearing loss have been accepted, would have been 
overamplified in hearing aid fitting, causing further damage to the auditory system. 
This discrepancy between behavioural and objective findings supports the study by Proops and 
Acharya (2009), who found that the reliability of behavioural tests depends on the skill of the tester 
as well as the state of the child; thus hearing may appear to be of a certain degree in behavioural 
testing owing to tester interpretation or a fatigued child, but may be of another degree in objective 
testing. Therefore, objective testing is particularly important in diagnosing hearing loss in a 
population with neurological disorders. 
Likewise, more patients were diagnosed with normal hearing on ABR testing. Objectively 45 ears 
were diagnosed with normal hearing, whereas only 8 ears presented with this degree of hearing 
when tested behaviourally. Only six out of the 80 ears tested correlated between behavioural and 
ABR results and all of these ears were normal-hearing. 
The above results obtained in this study suggest that behavioural testing was less sensitive at 
diagnosing both hearing loss and normal hearing than ABR testing for this study population, and 
confirms that some children can be misdiagnosed owing to lack of responses in behavioural 
audiometry, thus highlighting the need for objective testing in assessing auditory function in this 
population. This is consistent with the finding by Delaroche et al. (2004), who assert that some 
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multiply-handicapped children may never be able to be tested behaviourally and that objective 
testing will thus be vital in ascertaining their hearing status. 
 
Behavioural Testing in Neurologically Compromised Populations 
 
This study aimed to describe the results of behavioural testing in a sample of neurologically 
disordered children and those results obtained with objective ABR testing. In the study behavioural 
results were obtained in only 22 of the 80 ears (27.5% of the sample). No behavioural results could 
be obtained for 24 of 40 children. Four of these children were aged 5 or 6 months, thus behavioural 
testing was not attempted owing to their developmental capabilities. For six children behavioural 
testing was attempted but was aborted as the child could not be tested. For a further six children 
testing occurred in free-field, thus no ear-specific results were obtained. 
Aside from the four children aged 5 or 6 months, the sample were aged 7 months to 10 years, and 
are thus at the correct chronological age for behavioural testing. However, most of the children in 
this sample could not undergo behavioural testing owing to their developmental stage resulting 
from the neurological disorder. This is contrary to the findings of Madell (2008), who purports that 
by conducting estimates of the child’s developmental age, auditory information can be obtained in 
the same manner as normal-developing children with the same developmental age. This 
disagreement may be a result of some children in the sample having multiple neurological disorders, 
and others being severely developmentally delayed. The child’s developmental age is not estimated 
at CHBAH, as this is not part of the protocol for either behavioural or objective testing, which could 
also contribute to the discrepancy. 
However, as stated previously, it has been well established that behavioural audiometry remains the 
gold standard in hearing testing as it provides an estimate of the entire auditory system from the 
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outer ear to the auditory cortex (Delaroche et al., 2011), and should be utilized as a supplement to 
objective testing for neurologically disordered children (Lancioni et al., 1985). It is therefore vital 
that behavioural results be sought in all children, as objective testing does not give an overview of 
the entire auditory system. In this study population, however, most children were not able to 
undergo behavioural audiometry. In 20 children (half the study population) behavioural results were 
not even attempted. Behavioural audiometry needs to be included this into the test battery for 
every child in order to comply with the gold standard mentioned above. Therefore, based on the 
number of children in this population unable to cope in behavioural testing, this should be 
attempted later in the child’s development than in normally developing children. Preliminary 
habilitation should be based on objective results and altered as behavioural results are obtained 
after time. Behavioural results are important in holistic treatment of hearing impaired children, as 
stated above. 
In order to give the child with a neurological disorder the best chance of completing the task 
required for behavioural testing, Madell (2008) suggests making some adaptations to the test 
battery such as changing the stimulus, positioning the child appropriately, altering the expected 
response and presenting the stimulus differently. Behavioural testing should be attempted on this 
population with these adaptations; however interpretation by the tester should still be holistic, 
based on the case history, and cautious, ensuring that all results are cross-checked. The child may 
also need a number of sessions over which they are conditioned before they are able to understand 
the required response (Shoup & Roeser, 2007).With these adaptations and careful interpretation, 
behavioural testing may yield more results in this paediatric neurologically-disordered population 
than the current protocol if attempted at CHBAH. In this way the audiologist will gain information 
into the entire auditory system, and not just up to the auditory brainstem if only objective results 
are available. 
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All of the above indicates that results are difficult to obtain behaviourally for neurologically-
disordered children. A majority of this cohort did not yield any behavioural results, and thus hearing 
testing relied completely on objective measures. Objective testing, however, only provides 
information as far as the auditory brainstem and not higher. Behavioural testing offers an idea of 
how the sound is perceived and processed by the child up to the auditory cortex. It is therefore 
important and should not be overlooked in order to assess how the child processes sound, and not 
just how it is perceived. The children in this population should therefore undergo behavioural 
audiometry in addition to objective testing in order to evaluate the entire auditory system, and this 
behavioural test should be adapted for the child by obtaining multiple responses at the same 
intensities, using a test battery to cross-check results and altering the conditioned response 
according to the child’s developmental level. Interpretation of results should be holistic based on the 
entire testing battery. 
 
Difficulty Obtaining Behavioural Responses in Neurocompromised Populations 
 
In this study for those children for whom behavioural information was obtained, 72.7 % (16 out of 22 
ears) differed from the objective results. Of these 16 ears, 11 (68.8 %) presented with a worse 
degree of hearing than was diagnosed on objective testing. This is in fitting with the finding that 
children at lower developmental ages respond less to low-intensity sounds, thus hearing will appear 
worse than the true threshold (Diefendorf & Gravel, 2000). In order to respond the child must 
attend to the stimulus, and the nature of this response will vary between children, both of which are 
dependent on the level of neuromaturation (Delaroche et al., 2004). Low-functioning children may 
not even show an observable orientation response required for VRA such as a head turn (Lancioni et 
al., 1985). This difficulty in the child responding and the tester not recognizing the response would 
lead to hearing thresholds appearing worse than the child’s actual hearing abilities. In this way, 
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results obtained in behavioural testing are associated to the developmental level of the child 
(Diefendorf & Gravel, 2000), and is emphasized by the findings in this study that behavioural 
thresholds differ from objective results. 
More ears were diagnosed with a profound hearing loss on ABR testing than on behavioural testing 
in this sample (8 ears versus 3 ears respectively). None of these children diagnosed with a profound 
hearing loss objectively had any behavioural results. This could be a result of incorrect conditioning 
of the child behaviourally, leading to the tester aborting the test on the premise that the child “could 
not be conditioned”, and is consistent with the finding that should a child with a profound hearing 
loss be conditioned below the ear threshold, this child will not learn the conditioned response 
(Madell, 2008). Therefore, if a child does not appear to condition under headphones at loud 
intensities, vibrotactile conditioning with the bone oscillator should be attempted to ascertain 
whether this lack of response is a potential hearing loss or a result of developmental delay (Madell, 
2008). The fact that no child in this study diagnosed with a profound hearing loss objectively was 
able to be tested behaviourally emphasizes the importance of correct conditioning, as suggested by 
Madell (2008), and should be highlighted in the CHBAH behavioural protocol. All of these children 
with profound hearing loss barring one were diagnosed with CP, with the last child having a multiple 
diagnosis of meningitis and hydrocephalus. It is therefore possible that the more developmentally 
delayed children presented with the worst hearing abilities; however more investigation into this 
matter would be necessary to draw conclusive results. 
The Audiology Department at CHBAH services a large population, thus time pressure may lead to 
audiologists aborting the test and sending the child for an ABR in order to save time. The audiologist 
may therefore not include the adaptations and correct conditioning techniques that allow a 
neurologically-disordered child the best opportunity to respond in a behavioural hearing test, rather 
choosing to cease behavioural attempts. 
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The amount of clinical experience of the tester is negligible in this study as, according to the HPCSA 
regulations of undergraduate curriculum for Audiology, all students should be proficient in testing 
neurocompromised children in order to graduate. The Government Gazette states that a 
requirement of graduation for a Degree in Audiology is the assessment of central and peripheral 
hearing status in persons of any age in view of their communication needs (HPCSA, 2012). 
 
Hearing Loss with Regard to Diagnosis 
 
It is important to know the diagnosis of the child, as this can assist the audiologist in knowing if a 
hearing loss should be expected and what type of hearing loss to anticipate should this be 
synonymous with the diagnosis (Madell, 2008). The audiologist will also be able to gauge, by 
knowing the diagnosis, what to expect with speech, language and auditory behaviours, and to 
estimate the expected cognitive and developmental age of the child (Madell, 2008). Based on this 
knowledge, the test can be altered to account for the child’s needs, allowing the child the best 
opportunity to undergo reliable behavioural testing. Objective results can also be analyzed taking 
these factors into account. 
In this study sample, 43.75 % (n=35) of the ears tested presented with a hearing loss on objective 
testing. This indicates that hearing loss is more common in this neurologically-disordered population 
than in the general paediatric population where the incidence of hearing loss is three per 1000 live 
births, and emphasizes the necessity to conduct hearing testing on these patients. 
In terms of CP, of the 10 subjects diagnosed with this condition, four patients presented with 
bilateral profound hearing losses on ABR testing, and one patient presented with a unilateral 
profound hearing loss. Three presented with normal hearing bilaterally, and two presented with a 
moderate sloping to severe bilateral hearing loss. Therefore 40 % of this population was diagnosed 
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with a bilateral profound hearing loss, and half of the patients tested had a profound loss in at least 
one ear. There is a dearth of information on the trends in hearing loss in children with CP, however 
as stated previously, Rosenbaum et al. (2007) found that these children can have any amount of 
decibel loss. Further investigation with a larger sample could examine if, as this study indicates, 
profound hearing loss is the most common degree of hearing loss in children with CP. Owing to the 
fact that the subtype of CP was not documented on the patient record no conclusion can be drawn 
as to whether different hearing losses are more common in different types of CP. Further 
investigation into this matter would be necessary to obtain this information. 
Similarly, only one out of the five children (20 %) diagnosed with Down’s Syndrome presented with 
normal hearing in this study. Hearing loss was expected in this population based on studies 
mentioned previously that have found that these children present with fluctuating conductive 
hearing loss owing to the frequent otitis media present in a majority of this population as a result of 
the craniofacial structural abnormalities pertinent in this syndrome. Muscle hypertrophy common of 
the syndrome and hypertrophy of the mid-face lead to dysfunction of the eustachian tube, which 
contributes to the higher prevalence of otitis media and eventual hearing loss in this population as 
stated previously (Austeng et al., 2013). In this study sample, therefore, 80 % of children with 
Down’s Syndrome presented with a hearing loss. This percentage is higher than the 46.1% quoted in 
the study by Park et al. (2011) in Utah in America. This could be a result of some patients being 
diagnosed with normal hearing on screening measures in a diagnostic hearing evaluation. When VRA 
or CPA is not possible, screening is attempted with a screening Automated ABR and Otoacoustic 
Emmisions (OAEs). Patients passing this screening are discharged with a diagnosis of normal hearing 
and given a date for an annual hearing recheck. Patients referring the screening are booked for an 
ABR, therefore the population of children with Down’s Syndrome presenting in the ABR clinic at 
CHBAH will have a higher chance of presenting with a hearing loss as only those referring initial 
hearing screening will be seen for an ABR. 
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This higher incidence of hearing loss in the Down’s Syndrome subpopulation found in this study may 
also be in part attributed to the higher prevalence of CSOM in lower-resourced countries such as 
South Africa than in higher income countries where treatment and medical staff are more available 
(Mahadevan et al., 2012). The global burden of disease for CSOM lies in Africa, South-East Asia and 
the Western Pacific (Mahadevan et al., 2012); therefore more children will present with CSOM in 
South Africa and will thus be at higher risk of developing a hearing loss. 
Of the patients born prematurely in this sample, 54.5 % were diagnosed with a hearing loss on ABR 
testing. This is higher than the global prevalence of 5-10 % stated previously (Nour, 2012). However, 
this study by Nour (2012) included infants with prematurity only. Of the premature infants in this 
study only 3 had no concomitant conditions. The other 8 patients had other conditions that put 
them at risk of hearing loss, such as cerebral palsy, asphyxia, RVD and holoprosencephaly. Of these 
three patients with no concomitant conditions, two had a hearing loss. This could also be a result of 
the higher prevalence of CSOM mentioned above, as both these children had rising audiograms 
often associated with CSOM. 
This higher prevalence of hearing loss in the premature population in this study emphasizes the 
need for Newborn Hearing Screening. Universal newborn screening, whereby every infant is 
screened after birth, is the gold standard; however a lack of resources has prevented the instigation 
of this screening in South Africa (Friderichs et al., 2012). High-risk or targeted screening should, 
based on the results of this study, include at least all infants born prematurely. 
Prematurity, as indicated in Table 4, yielded the least amount of “no responses” in behavioural 
testing of any of the five other common pathologies. This indicates that these children are generally 
able to undergo behavioural testing, given extra time to allow for brain maturation. This finding is in 
agreement with Madell (2008), who states that premature infants should be tested in the same 
manner as term infants. However, given the higher prevalence of hearing loss in this premature 
population than that of the general population as found in this study, hearing losses would then be 
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diagnosed at a later stage if more time was allowed for maturation. Early intervention for those 
infants later diagnosed with hearing losses would then be less effective. 
Although both patients diagnosed with HIV/AIDS presented with a hearing loss in this study, both of 
these patients had concomitant diagnoses that could have caused hearing loss. One patient had 
Cytomegalovirus and CP, both of which have been shown to put children at risk of a hearing loss 
(Swanepoel, 2007). The other patient was born prematurely, which is also a risk factor in hearing 
loss (Swanepoel, 2007). 
Similarly, 43.4% of children with meningitis were found to have a sensorineural hearing loss of some 
degree post meningitis in Kenya, as reported by Karanja et al (2013). However, in this study three 
out of the five children with meningitis (or 60 %) were diagnosed with a hearing loss on ABR testing. 
One child had a bilateral profound hearing loss, however this child had hydrocephalus as well. The 
other two children had a mild bilateral hearing loss. This is higher than the prevalence stated by 
Karanja et al. (2013), thus further investigation would be necessary to establish the type of hearing 
loss (sensorineural or conductive) by bone conduction testing, and thus to establish if the loss is 
permanent or may resolve with medical intervention. The fact that 60 % of the study population 
with meningitis presented with hearing loss reiterates the need to test this population once a 
diagnosis of meningitis is received. 
In terms of hydrocephalus, the number of children in this study with hydrocephalus presenting with 
a hearing loss (one out of seven, or 14 %) is far lower than the average of 83 % stated above by 
Spirakis and Hurley (2003) in Tampa in America. However, this study by Spirakis and Hurley (2003) 
found high frequency cochlear losses on the side of the shunt. In this study high frequencies were 
not tested as tone-burst ABR was conducted up to 4kHz. Further testing such as OAEs should 
therefore be conducted on these children in order to rule out a high frequency hearing loss. Dixon 
and Jones (2012) found at the University of Kentucky in the United States of America that relieving 
intracranial pressure helped the hearing loss to resolve in most cases. All of the children in this study 
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had a ventriculoperitoneal shunt, thus pressure-related hearing loss may have resolved in some of 
these children. These patients should therefore be tested after the shunt is removed to check for 
remediation of hearing loss. 
It can be seen in Table 4 above that the three pathologies yielding the least behavioural results are 
those for which the highest percentage of hearing loss was diagnosed. These are Cerebral Palsy, RVD 
and Down’s Syndrome. This therefore emphasizes the importance of these children having their 
hearing tested, and the use of objective testing in obtaining results. 
 
HPCSA Risk Factors of Hearing Loss 
 
As mentioned previously, the HPCSA have identified children with the following conditions to be at 
risk of developing a hearing loss, and should therefore receive a hearing screen (Swanepoel, 2007): 
 An illness or condition requiring admission of 48 hours or greater to a NICU 
 Craniofacial abnormalities 
 In-utero infection such as cytomegalovirus, HIV 
 Postnatal infections associated with sensorineural hearing loss including bacterial meningitis 
For this study sample, out of the 40 patients selected, only 14 would have been at-risk if the above 
criteria were utilized. Very few of the patients born prematurely and those with birth asphyxia 
would fit the criteria of a 48 hour NICU admission. Most of these patients would have been moved 
out of the NICU as soon as they are stabilized and transferred to a high-care ward, thus not receiving 
hearing screening.  Similarly, a minority of those patients diagnosed with cerebral palsy would have 
been screened based on the HPCSA High Risk Register, as this condition would only manifest once 
the child is older and begins to fall behind motor milestones. 
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Nine of the 26 patients with conditions not recognized by the at-risk register were found to have a 
hearing loss in this sample, thus 22.5% of children with a hearing loss diagnosed in this study sample 
would not have received a hearing screen. These were children with CP, prematurity and birth 
asphyxia. This indicates the need to revise the criteria for targeted screening, including all patients 
with CP and/or asphyxia as well as those patients born prematurely. 
 
Early Intervention and Neurological Disorder 
 
It has been shown above that hearing loss is more prevalent in populations with neurological 
disorder than in the general paediatric population. It has similarly been proven that most of these 
patients are diagnosed with objective measures, as behavioural testing is unreliable in these 
children. According to the HPCSA in their position statement (Swanepoel, 2007), the guidelines for 
early intervention of hearing loss services in South Africa for hospital-based care are as follows: 
 Patients at risk should receive hearing screening before 28 days of age 
 Those referring on screening should receive diagnostic testing and a confirmation of hearing 
loss should be made before 3 months of age 
 The child should be enrolled in an early intervention programme before 6 months of age 
In this study, not one patient met the criteria above. For many of these children behavioural testing 
was attempted two or three times before a referral to the ABR clinic. This would delay the 
confirmation of hearing loss by a number of months. 
It is therefore suggested that all patients with neurological disorders are screened as soon as a 
diagnosis is made. Those children that do not pass hearing screening should be referred directly for 
objective testing in order for habilitation to begin. Behavioural testing should then be attempted, as 
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this is the only measure that gives an indication of the functioning of the entire auditory system 
from the outer ear to the auditory cortex (Delaroche et al., 2011). The child should be conditioned 
over a number of appointments with the above-mentioned adaptations to the conventional 
behavioural test in order to meet their individual developmental needs. However, this should be 
supplementary to enrollment in an early intervention programme in order to afford the child the 
best possible language and communication development resulting from early habilitation. Once 
behavioural results are obtained, amplification devices should be reprogrammed based on these 
results. 
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5. Conclusion 
 
Hearing loss is more prevalent in the paediatric population diagnosed with neurological disorders 
than the in general paediatric population. These neurologically-disordered children are more difficult 
to test with behavioural audiometry owing to their diagnoses. Behavioural thresholds are not 
possible in many members of this population, and those results obtained may be unreliable and lead 
to an incorrect diagnosis of the child’s hearing status. Therefore, objective testing via tone-burst ABR 
is very important in this population, and should be included in the initial hearing test battery for any 
children diagnosed with a neurological disorder. Aural habilitation should begin based on the results 
of objective testing. All children with a neurological disorder should receive hearing screening, and 
those children who do not pass the screen should immediately receive electrophysiological testing. 
Behavioural audiometry should not be ignored, but continually attempted with adaptations for the 
child’s developmental level in order to assess the entire auditory pathway up to and including the 
auditory cortex. Habilitation programmes should be based on objective measures initially, however 
once behavioural results are obtained the programme should be based on these, as this remains the 
gold standard and gives information of the entire auditory pathway. 
 
 
 
 
 
 
65 | P a g e  
 
6. Recommendations and Implications for the Study 
 
It can be seen above that neurological disorders are more common in developing countries such as 
South Africa than in higher-resourced, developed countries. Moreover, hearing loss is more common 
in neurologically-disordered children than in the general paediatric population. This study has shown 
that, owing to the fact that a majority of children with the above-mentioned pathologies presented 
with hearing loss, all children should be referred for a hearing test once a diagnosis of a neurological 
disorder is received. 
In order to test hearing, the results of these children should be based on both objective and 
behavioural test battery results. This study has shown that behavioural testing in isolation is of 
limited value, and will only be able to be conducted once the child is of a sufficient developmental 
age to understand the test. Objective testing should therefore be conducted in order to ascertain 
the status of the child’s peripheral hearing system from the outer ear up to and including the eighth 
cranial nerve. Enrollment in a habilitation programme should be based on these results. The child 
should continually be conditioned for a developmentally-appropriate behavioural test battery, with 
alterations to encompass the child’s unique abilities, in order to assess the entire auditory system up 
to the auditory cortex. 
All children with a neurological disorder should have access, therefore, to both behavioural and 
objective testing. In District and Rural hospitals in South Africa there is currently a dearth of both, 
with a majority of the caseload falling on Tertiary hospitals such as CHBAH. Therefore, more 
appropriately-trained audiologists and relevant equipment should be allocated to District and Rural 
hospitals in order to afford children in these areas the opportunity for hearing and communication 
habilitation. 
It is thus recommended that Universal Newborn Hearing Screening be implemented. Failing this, due 
to a lack of resources, all children diagnosed with a neurological disorder should immediately be 
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referred for a hearing test. This should comprise of both behavioural and objective testing, thus all 
equipment for these tests (namely diagnostic audiometers, VRA conditioning toy boxes, speakers for 
freefield testing, immittance equipment and an electrophysiological testing unit) should be available 
to the audiology department. Audiologists and the above-mentioned equipment should be allocated 
to hospitals of all levels ensuring that no patient is without the option of a hearing test. 
Further research should be conducted into the typical responses in behavioural audiometry by 
children with neurological disorders. By knowing what responses to expect, the clinician will be able 
to garner as much behavioural information as possible, thereby gaining more insight into the child’s 
auditory processing capabilities. 
Research should also be conducted into exact alterations that could be made to the behavioural test 
battery according to the child’s diagnosis. These alterations would make it more likely that the child 
would respond, and lead to more behavioural information being obtained. 
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7. Limitations of the Study 
 
This study comprised of only 40 subjects. Some of the pathologies studied were present in only one 
or two of the subjects, thus it cannot be generalized to the population. Hydrocephalus and CP were 
utilized as “blanket terms” for these conditions, and children in the different sub-groups of these 
pathologies were not separated. Similarly, the nature of the data and the small number of subjects 
resulted in the ABR records not being viable for statistical analysis. 
Bone conduction testing results were not available for many children. Many of the subjects were 
diagnosed with a mild hearing loss in the presence of abnormal Type B tympanometry, indicating 
middle ear effusion. According to the CHBAH protocol, these children would have been sent for ENT 
management and booked for a recheck assessment in 8 – 10 weeks, thus bone conduction testing 
was rarely conducted. Tympanometric results were not included in the study, so it cannot be stated 
whether subjects in this sample present with a permanent or a temporary hearing loss.  
Bone conduction cannot be tested on the Eclipse equipment at intensities exceeding 40 – 50 dBnHL, 
owing to stimulus artifact. Therefore, for those children presenting with profound hearing losses, 
bone conduction testing would have most likely yielded no identifiable waveforms at maximum 
stimulus levels. For these children it is assumed that the type of hearing loss is sensorineural, 
however this would not be able to be confirmed objectively. 
The cohort of children in this study was mostly affected by more than one neurological disorder. For 
these children with multiple disabilities, it is difficult to report on the prevalence of hearing loss per 
pathology as found in this study as it is confounded by the multiple handicaps. 
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9. Appendices 
Appendix 1: Severity of Hearing Loss 
 
Degree of Hearing Loss Pure Tone Average (dBHL) 
Normal Hearing < 15 
Slight Hearing Loss 16 – 25 
Mild Hearing Loss 26 – 40 
Moderate Hearing Loss 41 - 55 
Moderately-severe Hearing Loss 56 – 70 
Severe Hearing Loss 71 – 90 
Profound Hearing Loss >  90 
 
Reproduced from Typically Used Categories to Describe the Degree of Hearing Loss based on the 
Pure-Tone Average (p. 144) by Gelfand (2009). 
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Appendix 2: Correction Factors for ABR Testing 
The following correction factors were utilized in ABR testing in order to convert the threshold 
obtained in the ABR (which is in dBnHL) to an estimated hearing level in dBeHL. 
 Click 500 Hz 1000 Hz 2000 Hz 4000 Hz 
Under 12 weeks 
corrected age 
-5 -15 -10 -5 0 
12 - 24 weeks corrected 
age (AC & BC) 
0 -20 -15 -10 -5 
Over 24 weeks 
corrected age (AC & BC) 
- 5 -20 -15 -10 -10 
Correction Values for Air Conduction ABR under Insert Earphones 
 
Adapted from: 
Guidelines for early audiological assessment and management of babies referred from the newborn 
hearing screening programme (Version2.5) by Stevens et al (2011). 
 
 
 
 
 
 
82 | P a g e  
 
Appendix 3: Letter to the Ethics Committee at Chris Hani Baragwanath Academic 
Hospital Requesting Permission to Use Patient Data 
 
83 | P a g e  
 
 
 
 
84 | P a g e  
 
Appendix 4: Letter of Permission from the Head of Department of Audiology at 
Chris Hani Baragwanath Academic Hospital 
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Appendix 5: Medical Ethics Committee Clearance Certificate 
 
Ethical clearance was obtained from the Human Research Ethics Committee (Medical) at the 
University of the Witwatersrand on 24.02.2012. 
The Ethical Clearance Certificate for Protocol Number M120217 was obtained. 
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Appendix 6: Spreadsheet Containing a Summary of All Data, Per Participant 
 
Patient No D.O.B Age 
(months) 
Diagnosis 
1 02.01.2011 11 Down Syndrome 
2 22.05.2007 53 CP 
3 25.03.2011 7 Chromosomal Abnormality 
4 01.11.2010 11 SMA, RVD, Prematurity 
5 01.03.2011 5 Prematurity, Asphyxia 
6 28.05.2009 31 CP 
7 08.05.2010 11 Prematurity, Asphyxia, CP 
8 14.03.2011 7 Asphyxia 
9 17.02.2010 22 Unknown Syndrome 
10 08.03.2011 6 Prematurity, Asphyxia 
11 29.08.2007 52 CP 
12 22.01.2007 54 Unknown Syndrome, TB 
13 31.12.2007 47 Butler Syndrome 
14 14.06.2007 47 CP, cerebral atrophy, asphyxia 
15 21.01.2009 28 Trisomy 18, cleft lip and palate 
16 30.12.2009 25 Hydrocephalus, developmental delay 
17 08.05.2010 22 Hydrocephalus, blindness 
18 17.06.2011 8 Meningitis 
19 01.08.2011 7 Prematurity, asphyxia 
20 29.01.2005 84 CP, microcephaly 
21 28.07.2011 5 Prematurity 
22 18.07.2010 19 Down Syndrome 
23 19.12.2008 39 Autism 
24 15.04.2011 7 Prematurity 
25 12.10.2009 29 Prematurity, holoprosencencephaly 
26 19.08.2011 5 Down Syndrome 
27 04.08.2010 22 Corpus callosum agenesis, cleft lip and palate 
28 11.07.2011 5 Prematurity 
29 06.03.2008 48 CP, seizures 
30 04.05.2010 22 CP, CMV, RVD 
31 07.07.2002 115 Meningitis, hydrocephalus 
32 01.12.2008 39 Hydrocephalus 
33 27.08.2011 6 Meningitis 
34 27.12.2010 13 Hydrocephalus, spina bifida, meningitis, prem 
35 25.12.2006 62 Down Syndrome 
36 12.05.2011 7 Down Syndrome 
37 14.03.2007 60 Hydrocephalus, meningitis 
38 01.07.2009 31 CP 
39 09.07.2009 31 Hydrocephalus 
40 03.03.2010 22 CP, prematurity 
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Left Ear ABR Right Ear ABR 
Patient 
No 
500 Hz 1 000 
Hz 
2 000 
Hz 
4 000 
Hz 
500 
Hz 
1 000 Hz 2 000 Hz 4 000 Hz 
1 n/a 55 n/a 30 n/a 55 n/a 30 
2 NR 80 NR 85 NR 90 NR 80 NR 80 NR 85 NR 90 NR 80 
3 n/a n/a n/a 0 n/a n/a n/a <10 
4 70 n/a n/a 5 50 n/a n/a 10 
5 n/a 25 n/a 20 n/a <15 n/a <15 
6 n/a 35 n/a 25 n/a 70 n/a 40 
7 n/a 25 n/a 50 50 n/a n/a 85 
8 n/a n/a n/a 0 n/a n/a n/a -5 
9 <25 <25 <25 <25 n/a 30 n/a <20 
10 25 <15 <20 <20 25 <15 <20 <20 
11 n/a n/a n/a <20 n/a n/a n/a <20 
12 n/a <25 n/a <25 n/a <25 n/a 35 
13 n/a n/a n/a <10 n/a n/a n/a <10 
14 <20 <20 <15 <20 n/a n/a n/a n/a 
15 n/a n/a n/a <30 n/a n/a n/a n/a 
16 n/a <25 n/a <25 n/a n/a n/a <25 
17 <30 25 n/a <20 <30 <15 n/a <25 
18 n/a <20 n/a <20 n/a <25 n/a <25 
19 n/a n/a 50 65 n/a n/a 25 60 
20 NR 75 NR 85 NR 90 NR 85 NR 75 NR 85 n/a NR 85 
21 NR 80 85 80 45 70 60 40 <25 
22 n/a n/a n/a 50 n/a n/a n/a n/a 
23 n/a <25 n/a <25 n/a <25 n/a <20 
24 <25 <25 n/a <25 <25 <25 n/a <25 
25 n/a n/a n/a <20 n/a n/a n/a <20 
26 35 <25 n/a <25 <25 <25 n/a <25 
27 n/a <25 n/a <25 n/a <25 <25 <20 
28 40 75 65 65 n/a <15 <30 25 
29 n/a <15 n/a <20 n/a <30 n/a <30 
30 n/a n/a n/a 35 n/a NR 85 NR 90 NR 85 
31 n/a NR 85 90 NR 85 n/a NR 85 80 70 
32 n/a n/a n/a <30 n/a n/a n/a n/a 
33 n/a 35 n/a 30 n/a 50 40 35 
34 n/a <30 n/a <30 n/a <35 n/a <40 
35 <60 40 40 <25 n/a 30 30 <25 
36 <20 <25 n/a <25 n/a <25 n/a <25 
37 n/a <35 n/a <20 n/a n/a n/a <30 
38 80 NR 85 NR 90 NR 85 100 NR 100 NR 100 NR 95 
39 25 <25 30 <25 <25 <25 30 <25 
40 NR 80 NR 85 NR 90 NR 85 NR 80 NR 85 90 NR 85 
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  Left Ear Behavioural Right Ear Behavioural 
Patient 
No 
500 Hz 1 000 
Hz 
2 000 
Hz 
4 000 
Hz 
500 Hz 1 000 Hz 2 000 
Hz 
4 000 
Hz 
1                 
2                 
3                 
4                 
5                 
6 NR 115 NR 115 NR 115 NR 110 NR 110 NR 115 NR 110 NR 105 
7 35 n/a n/a 15 10 10 10 n/a 
8                 
9 n/a n/a n/a n/a 80 85 85 85 
10                 
11                 
12                 
13 40 40 40 40 40 40 40 40 
14                 
15         100   55   
16                 
17                 
18 n/a n/a n/a n/a n/a 40 40 n/a 
19                 
20                 
21                 
22 CNT CNT CNT CNT CNT CNT CNT CNT 
23   25     25 30 25 25 
24                 
25                 
26 CNT CNT CNT CNT CNT CNT CNT CNT 
27                 
28                 
29 CNT CNT CNT CNT   50 40 50 
30 CNT CNT CNT CNT CNT CNT CNT CNT 
31                 
32 70 60 55   60 60 50 30 
33 20   20 20 30 20   20 
34                 
35 CNT CNT CNT CNT CNT CNT CNT CNT 
36                 
37 CNT CNT CNT CNT CNT CNT CNT CNT 
38                 
39                 
40                 
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  Free Field 
Patient 
No 
500 Hz 1000 Hz 2000 Hz 4000 Hz 
1         
2         
3         
4         
5   25 25   
6         
7         
8         
9         
10         
11         
12   <25   <25 
13         
14         
15         
16 20 20 20 20 
17         
18         
19         
20         
21 30 25 25 25 
22         
23         
24 30 30 30 30 
25         
26         
27         
28         
29         
30         
31         
32         
33         
34         
35         
36         
37         
38         
39   85 90   
40         
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Patient 
No 
D.O.B Age 
(months) 
Diagnosis 
1 02.01.2011 11 Down Syndrome 
2 22.05.2007 53 CP 
3 25.03.2011 7 Chromosomal Abnormality 
4 01.11.2010 11 SMA, RVD, Prematurity 
5 01.03.2011 5 Prematurity, Asphyxia 
6 28.05.2009 31 CP 
7 08.05.2010 11 Prematurity, Asphyxia, CP 
8 14.03.2011 7 Asphyxia 
9 17.02.2010 22 Unknown Syndrome 
10 08.03.2011 6 Prematurity, Asphyxia 
11 29.08.2007 52 CP 
12 22.01.2007 54 Unknown Syndrome, TB 
13 31.12.2007 47 Butler Syndrome 
14 14.06.2007 47 CP, cerebral atrophy, asphyxia 
15 21.01.2009 28 Trisomy 18, cleft lip and palate 
16 30.12.2009 25 Hydrocephalus, developmental delay 
17 08.05.2010 22 Hydrocephalus, blindness 
18 17.06.2011 8 Meningitis 
19 01.08.2011 7 Prematurity, asphyxia 
20 29.01.2005 84 CP, microcephaly 
21 28.07.2011 5 Prematurity 
22 18.07.2010 19 Down Syndrome 
23 19.12.2008 39 Autism 
24 15.04.2011 7 Prematurity 
25 12.10.2009 29 Prematurity, holoprosencencephaly 
26 19.08.2011 5 Down Syndrome 
27 04.08.2010 22 Corpus callosum agenesis, cleft lip and palate 
28 11.07.2011 5 Prematurity 
29 06.03.2008 48 CP, seizures 
30 04.05.2010 22 CP, CMV, RVD 
31 07.07.2002 115 Meningitis, hydrocephalus 
32 01.12.2008 39 Hydrocephalus 
33 27.08.2011 6 Meningitis 
34 27.12.2010 13 Hydrocephalus, spina bifida, meningitis, prem 
35 25.12.2006 62 Down Syndrome 
36 12.05.2011 7 Down Syndrome 
37 14.03.2007 60 Hydrocephalus, meningitis 
38 01.07.2009 31 CP 
39 09.07.2009 31 Hydrocephalus 
40 03.03.2010 22 CP, prematurity 
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Patient 
No 
Hearing Result Objective RE Hearing Result Objective LE 
1 Moderately-severe to mild HL Moderately-severe to mild HL 
2 Profound HL Profound HL 
3 Normal hearing Normal hearing 
4 Moderately-severe to mild HL Moderately-severe to mild HL 
5 Normal hearing Normal hearing 
6 Severe rising to moderate HL Mild HL 
7 Moderate sloping to severe HL Moderate high frequency HL 
8 Normal hearing Normal hearing 
9 Normal hearing Normal hearing 
10 Normal hearing Normal hearing 
11 Normal hearing Normal hearing 
12 Normal hearing Normal hearing 
13 Normal hearing Normal hearing 
14 Normal hearing Normal hearing 
15 Normal hearing Normal hearing 
16 Normal hearing Normal hearing 
17 Normal hearing Normal hearing 
18 Normal hearing Normal hearing 
19 Moderate sloping to severe high freq HL Moderate sloping to moderately-severe HL 
20 Profound HL Profound HL 
21 Severe rising to normal Profound rising to moderately-severe HL 
22 Moderately-severe HL Moderately-severe HL 
23 Normal hearing Normal hearing 
24 Normal hearing Normal hearing 
25 Normal hearing Normal hearing 
26 Mild low frequency HL Mild low frequency HL 
27 Normal hearing Normal hearing 
28 Normal hearing Moderate sloping to severe HL 
29 Normal hearing Normal hearing 
30 Profound HL Mild HL 
31 Profound rising to severe HL Profound HL 
32 Normal hearing Normal hearing 
33 Moderate rising to mild HL Mild HL 
34 Mild HL Mild HL 
35 Mild to moderate HL Mild to moderate HL 
36 Normal hearing Normal hearing 
37 Normal hearing Normal hearing 
38 Severe to Profound HL Severe to Profound HL 
39 Normal hearing Normal hearing 
40 Profound HL Profound HL 
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Patient 
No 
Hearing Result Behavioural RE Hearing Result Behavioural LE 
1 None None 
2 None None 
3 None None 
4 None None 
5 Normal hearing None 
6 Profound HL Profound HL 
7 Normal hearing Normal hearing 
8 None None 
9 Profound HL None 
10 None None 
11 None None 
12 Normal hearing None 
13 Moderate hearing loss Moderate hearing loss 
14 None None 
15 Profound rising to moderately-severe HL None 
16 Normal hearing None 
17 None None 
18 Moderate hearing loss None 
19 None None 
20 None None 
21 Normal hearing None 
22 None None 
23 Normal hearing Normal hearing 
24 Normal hearing None 
25 None None 
26 None None 
27 None None 
28 None None 
29 Moderate hearing loss None 
30 None None 
31 None None 
32 Moderately-severe rising to mild HL Severe rising to moderately-severe HL 
33 Normal hearing Normal hearing 
34 None None 
35 None None 
36 None None 
37 None None 
38 None None 
39 Severe to profound HL None 
40 None None 
 
